<SUBMISSION>
<ACCESSION-NUMBER>0001144204-12-014046
<TYPE>SC 14D9/A
<PUBLIC-DOCUMENT-COUNT>4
<FILING-DATE>20120309
<DATE-OF-FILING-DATE-CHANGE>20120309
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME>ATS CORP
<CIK>0001325460
<ASSIGNED-SIC>8742
<IRS-NUMBER>113747950
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>SC 14D9/A
<ACT>34
<FILE-NUMBER>005-81087
<FILM-NUMBER>12681210
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
<PHONE>571-766-2400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Federal Services Acquisition CORP
<DATE-CHANGED>20050429
</FORMER-COMPANY>
</SUBJECT-COMPANY>
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME>ATS CORP
<CIK>0001325460
<ASSIGNED-SIC>8742
<IRS-NUMBER>113747950
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>SC 14D9/A
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
<PHONE>571-766-2400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Federal Services Acquisition CORP
<DATE-CHANGED>20050429
</FORMER-COMPANY>
</FILED-BY>
<DOCUMENT>
<TYPE>SC 14D9/A
<SEQUENCE>1
<FILENAME>v304809_sc14d-9a.htm
<DESCRIPTION>SCHEDULE 14D9/A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14D-9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amendment No. 2)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SOLICITATION/RECOMMENDATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STATEMENT UNDER SECTION 14(d)(4) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ATS Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Name of Subject Company)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ATS Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Name of Person Filing Statement)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK, PAR VALUE $0.0001 PER SHARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Title of Class of Securities)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>00211E104</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(CUSIP Number of Class of Securities)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pamela Little</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Co-Chief Executive Officer and Chief
Financial Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ATS Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>7925 Jones Branch Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>McLean, VA 22102</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone: (571) 766-2400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Name, address and telephone numbers
of person authorized to receive notices and</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>communications on behalf of the persons
filing statement)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>With copies to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Squire Sanders (US) LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1200 19<SUP>th</SUP> Street, NW<BR>
Suite 300<BR>
Washington, D.C. 20036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Attention: James J. Maiwurm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone: (202) 626-6600</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 23.75pt"> <FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;&nbsp;Check the box if the filing relates
solely to preliminary communications made before the commencement of a tender offer.</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 23.75pt">This Amendment No. 2 (this &ldquo;<U>Amendment</U>&rdquo;)
amends and supplements the Solicitation/Recommendation Statement on Schedule 14D-9 (together with any amendments and supplements
thereto, the &ldquo;<U>Schedule 14D-9</U>&rdquo;) filed with the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;)
on February 29, 2012, as amended by the Amendment No. 1 to the Schedule 14D-9 filed on March 6, 2012, and as filed by ATS Corporation,
a Delaware corporation (&ldquo;<U>ATS</U>&rdquo; or the &ldquo;<U>Company</U>&rdquo;). The Schedule 14D-9 relates to the tender
offer by Atlas Merger Subsidiary, Inc., a Delaware corporation (the &ldquo;<U>Offeror</U>&rdquo;) and wholly owned subsidiary of
Salient Federal Solutions, Inc., a Delaware corporation (&ldquo;<U>Parent</U>&rdquo;), to purchase all outstanding shares of our
common stock, par value $0.0001 per share (the &ldquo;<U>Shares</U>&rdquo;), at $3.20 per Share in cash, without interest, upon
the terms and subject to the conditions set forth in the Offer to Purchase, dated February 28, 2012 (the &ldquo;<U>Offer to Purchase</U>&rdquo;),
and in the related Letter of Transmittal (which, together with any amendments or supplements, collectively constitute the &ldquo;<U>Offer</U>&rdquo;).
The Offer is described in a Tender Offer Statement on Schedule TO filed by the Offeror and Parent with the SEC on February 28,
2012, as amended by the Amendment No. 1 to the Schedule TO filed on March 1, 2012, the Amendment No. 2 to the Schedule TO filed
on March 6, 2012<B> </B>and the Amendment No. 3 to the Schedule TO filed on March 9, 2012. The Offer to Purchase and the Letter
of Transmittal were filed with the Schedule 14D-9 as Exhibits (a)(1)(A) and (a)(1)(B), respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 23.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 23.75pt">Except as otherwise set forth below, the
information set forth in the Schedule 14D-9 remains unchanged and is incorporated by reference as relevant to the items in this
Amendment. Capitalized terms used and not defined herein shall have the meanings assigned to such terms in the Schedule 14D-9.
This Amendment is being filed to reflect certain updates as reflected below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 23.75pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-size: 10pt; font-weight: bold">ITEM 4.</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-size: 10pt; font-weight: bold">THE SOLICITATION OR RECOMMENDATION.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Item 4 of the Schedule 14D-9 is hereby amended
by amending and restating all of the text under the heading &ldquo;<I>Background of the Offer and Reasons for Recommendation</I>&rdquo;
with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Background of the Offer and Reasons for Recommendation
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt"><I>Background of the Offer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">From time to time, the Company Board has
proactively considered strategic transactions as a means of maximizing stockholder value. The Company has, in recent times, struggled
with significant external factors, such as the timing of new contract awards, uncertainties as to federal government budgets, and
a slowdown in government procurement and spending. In addition, during the fall of 2010 holders of significant blocks of the Company&rsquo;s
stock indicated their desire to management and the Board that the Company consider a sale scenario. In January 2011, the Company
Board discussed various alternatives and authorized management to evaluate possible strategic alternatives for the Company, including
consideration of a sale of the Company or a similar strategic transaction. Inherent in the decision to assess strategic alternatives
was a decision to continue to operate the business with strong EBITDA margins and not to make investments in the future such as
recruiting additional high caliber personnel to fill key operating, sales and development positions that would focus on organic
and strategic growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Accordingly, on January 7, 2011, the Company
publicly announced that it had begun a process to evaluate strategic alternatives, and on January 20, 2011, the Company engaged
Sagent Advisors Inc. (&ldquo;<I>Sagent</I>&rdquo;) to assist and advise the Company Board in its review of such strategic alternatives.
The Company and Sagent executed an engagement letter setting forth the terms of Sagent&rsquo;s engagement as independent financial
advisor to the Company. On January 24, 2011, Sagent, members of the Company&rsquo;s management team and members of the Company&rsquo;s
Board met to organize the strategic alternatives process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 15, 2011, on a teleconference
between Parent and representatives of Sagent, Parent expressed an informal interest in discussing a business transaction with the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On March 8, 2011, at the direction of the
Company Board, Sagent began contacting a wide range of 99 potentially interested parties, both strategic and financial, to evaluate
parties&rsquo; interest in acquiring the Company. After confirming such interest, the Company executed confidentiality agreements
and provided confidential information packages for review to 34 interested parties. In particular, the Company entered into a confidentiality
agreement with Parent on March 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On April 8, 2011, the Company Board held
a conference call and received an update of the status of the assessment of strategic alternatives and contacts with potentially
interested parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On April 19, 2011, at the direction of the
Company Board, Sagent notified the remaining 20 interested parties that the bid date would be postponed until further notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On May 13, 2011, at the direction of the
Company Board, Sagent distributed a supplemental information packet, containing updated information from the Company&rsquo;s management
team, including a downward revision of the Company&rsquo;s financial forecast, to 19 interested parties, including Parent, and
also informed the interested parties of a targeted initial bid date of May 20, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On May 16, 2011, the Company announced its
results of operation for the first fiscal quarter of 2011 and revised its earnings guidance downward for the fiscal year ending
December 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On May 20, 2011, the Company received a written,
non-binding indication of interest from Parent to acquire the Company for an enterprise value range of $100 million to $120 million.
From June through August 2011, the Company provided Parent with a management presentation, answered its questions and provided
Parent with the opportunity to conduct more detailed due diligence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On May 24, 2011, the Company Board held a
meeting at the Company&rsquo;s headquarters, with representatives from Sagent and counsel for the Company in attendance, as well
as members of Company management. Sagent discussed the process to date, commenting on the number of parties contacted and those
that had executed non-disclosure agreements to date. Sagent noted that a supplemental information packet with the revised financial
forecast had been distributed on May 13, 2011. Sagent then provided an overview of those parties contacted and their current interest
status, as well as a summary of the general feedback received from both the interested parties and those that had declined to participate
in the bid process. The Company Board discussed the analysis and feedback in detail, asked questions of Sagent and management,
particularly in relation to management&rsquo;s revised forecast, associated adjusted EBITDA margins, and the impact of the current
challenging market environment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">During the summer months and continuing through
the fall, the Company Board conducted regular&mdash;often on a weekly basis&mdash;telephone conferences with Company management,
and often representatives of Sagent and the Company&rsquo;s outside legal counsel, Squire Sanders (US) LLP, to discuss the progress
of the strategic evaluation process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On June 24, 2011, the Company&rsquo;s management
conducted a management presentation with Parent at the offices of counsel for the Company. Following the presentation, Parent was
granted access to an online data room, which contained detailed financial, operating and other information about the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On June 29, 2011, Parent informed Sagent
that it was revising its enterprise valuation range to $80 million to $85 million. On the same day, the Company revoked Parent&rsquo;s
access to its dataroom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On July 5, 2011, Parent reiterated its interest
and suggested that it might be able to reach an enterprise value of $90 million or more.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On July 8, 2011, the Company Board held a
special meeting at the offices of CM Equity Partners in New York City, with representatives of counsel for the Company present
in person and Sagent in attendance telephonically, as well as members of Company management. The purpose of this meeting was to
obtain an update on negotiations with the potential buyer who was furthest in the process at the time, Parent. Representatives
of Sagent explained that the management presentations had gone well with Parent, but that Parent had communicated it was considering
a revised bid below the initial anticipated range, primarily as a result of some concerns about the Company achieving its 2011
revenue targets. The Company Board discussed whether, given the downward movement in Parent&rsquo;s indicated price range, it made
sense to continue discussions with Parent. The Company Board noted that a longer-term course of action to enhance stockholder value
would involve additional investment over time and would result in increased uncertainty, and the risk associated with such uncertainty
could have a short-term negative effect on the Company, in particular with regard to the Company&rsquo;s staffing and the risk
of possible loss of value that could arise through the loss of key personnel. After a lengthy discussion, the Company Board determined
that the strategic alternatives evaluation process should continue and discussions with Parent should be pursued as a part of that
process until the Company Board knew with more certainty what price Parent was willing to pay for the Company, as well as pricing
and interest levels from other parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On July 13, 2011, the Company granted Parent
access to its dataroom again.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On July 21, 2011, at the direction of the
Company Board, Sagent contacted 11 additional parties that had previously expressed interest in the Company but had initially declined
further involvement in pursuing a transaction because of valuation concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On July 25, 2011, the Company announced its
results of operation for the second fiscal quarter of 2011 and, at the direction of the Company Board, Sagent distributed a second
supplemental information packet from the Company&rsquo;s management team, containing a slight downward revision to the Company&rsquo;s
financial forecast, to eight interested parties, including Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On July 27, 2011, the Company&rsquo;s management
hosted Parent for a detailed program review presentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On August 1, 2011, Dr. Bersoff and Ms. Little
discussed with counsel for the Company both the process of Company discussions with its major stockholders as the strategic evaluation
process evolved, and also the process for a potential tender offer. They also addressed whether the Company should obtain a fairness
opinion in connection with any proposed transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On August 4, 2011, Party A, who Sagent had
reached out to initially and also a second time, submitted an indication of interest to acquire the Company for an enterprise value
range of $95 million to $105 million, or $3.85 to $4.25 per share. Also on August 4, 2011, Sagent received a call from Party B,
who had previously been contacted by Sagent, expressing interest in re-engaging in the process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On August 8, 2011, Party C, who Sagent reached
out to initially and also a second time, submitted an indication of interest to acquire the Company for $3.00 to $3.50 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On August 17, 2011, the Company&rsquo;s management
hosted Party C for a management presentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On August 25, 2011, the Company&rsquo;s management
hosted Party A for a management presentation. Also on August 25, 2011, Party B submitted an indication of interest to acquire the
Company for $3.50 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On August 30, 2011, the Company&rsquo;s management
held a telephonic management presentation with Party B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On August 31, 2011, Party A and Party B declined
to continue pursuing the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On September 13, 2011, at the direction of
the Company Board, Sagent distributed a third supplemental information packet, containing a revised financial forecast from the
Company&rsquo;s management team, to Parent and Party C, which contained a downward revision to the financial forecast. The packet
included an instruction letter and draft Merger Agreement seeking refined proposals to acquire control of the Company. Responses
were due on September 22, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Company management hosted Party C for a detailed
program review presentation on September 16, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On September 19, 2011, the Company&rsquo;s
management hosted Parent for another detailed program review presentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On September 22, 2011, Parent submitted an
offer to acquire the Company for $3.40 per share, and on September 23, 2011, Party C submitted an offer to acquire the Company
for $3.35 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On September 26, 2011, the Company Board
held a meeting at the Company&rsquo;s headquarters, also attended by representatives of Sagent and counsel for the Company, as
well as members of Company management. Representatives of Sagent gave the Company Board an update on Sagent&rsquo;s activities
associated with the Company&rsquo;s evaluation of strategic alternatives, including an overview of the history of the discussions
with potentially interested parties. In particular, Sagent reviewed in detail the proposals that had been received from the two
parties, commenting on subjects such as the purchase price offered, the speed with which the parties might be willing and able
to proceed, and possible transaction structure. The Company Board directed Sagent to continue discussions with the two interested
parties, with a focus on negotiating a higher price and eliminating as much &ldquo;conditionality&rdquo; as possible. The Company
Board also discussed the possibility of providing for a bonus arrangement to Ms. Little and Mr. Hassoun upon closing of the transaction,
but no decision was reached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">At the Company Board&rsquo;s direction, on
September 27, 2011, Sagent contacted Parent and Party C to discuss certain terms of each offer and also request an increase in
offer price per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On September 28, 2011, the Company&rsquo;s
counsel provided Parent&rsquo;s counsel with a draft Support Agreement, pursuant to which certain large stockholders of the Company
would agree to tender a portion of their shares in the Offer. Also on September 28, 2011, the Company&rsquo;s counsel provided
Parent&rsquo;s counsel with a revised draft Merger Agreement, following discussions between the two counsels of Parent&rsquo;s
initial review of the prior draft provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On September 29, 2011, at the Company Board&rsquo;s
direction, Sagent circulated a revised fiscal year 2011 financial forecast from the Company&rsquo;s management team to Party C
and Parent, the two parties from which it had received offers. The update included several contract wins and losses, with a net
effect of a slight downward revision to the financial forecast. Also on September 29, 2011, Sagent received an updated offer from
Parent to acquire the Company for $3.50 per share, along with a revised draft of the Merger Agreement and a proposed draft Exclusivity
Agreement. Party C declined to submit an increased offer for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On September 30, 2011, the Company Board
held a telephonic meeting with representatives of Sagent and counsel for the Company joining, as well as members of Company management.
Sagent reported on further discussions with representatives of both parties that had extended offers. Sagent explained that Parent
had increased its proposed purchase price from $3.40 per share to $3.50 per share. The structure of the proposed transaction was
discussed at length, involving an initial tender offer either with a 90% minimum tender condition, followed by a short form merger
or, if necessary, long form merger. The Board discussed valuation, the impact of the Company&rsquo;s lower fourth quarter projections,
whether a higher price could be negotiated, and the relevant risks of the Parent proposal, including the risk that Parent might
not be able to obtain financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">At Dr. Bersoff&rsquo;s request, counsel for
the Company commented on the nature of the relevant legal issues presented, including a brief review of the Board&rsquo;s fiduciary
duties, as well as the discussions it had held with representatives of Morrison &amp; Foerster, counsel for Parent. Representatives
of Sagent also reported that Party C had a substantial amount of diligence remaining and was not willing to increase its proposed
$3.35 per share offering price. After full discussion, the Company Board directed Sagent to continue discussions with Parent in
an effort to improve the proposed price, and counsel for the Company was authorized to engage in dialogue with counsel for Parent
to narrow the open issues in relation to the draft Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 1, 2011, counsel for the Company,
on behalf of the Company, circulated a revised draft of the Merger Agreement and a revised draft Exclusivity Agreement to counsel
for Parent. On the same date, Parent and the Company met to formally initiate extensive due diligence efforts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 2, 2011, the Company&rsquo;s counsel
and Parent&rsquo;s counsel held a teleconference to discuss the terms of the Merger Agreement. On the same date, representatives
of each of Sagent and Parent held a teleconference to discuss Parent&rsquo;s proposed offering price, during which Sagent requested
an additional increase to Parent&rsquo;s offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 3, 2011, at the Company Board&rsquo;s
request, Sagent contacted Parent to again request that it increase the offer price per share; Parent declined to submit a revised
offer. Also on October 3<SUP>rd</SUP>, the Company Board held a telephonic meeting with representatives of Sagent and counsel for
the Company joining, as well as members of Company management. Representatives of Sagent reported that Parent was continuing to
propose a purchase price of $3.50 per share, subject to a number of contingencies, including completion of due diligence and obtaining
financing. Counsel for the Company reported that some progress had been made on the Merger Agreement, although significant issues
remained outstanding, including Parent&rsquo;s insistence upon a minimum 90% tender condition. The Company Board and Company management
extensively discussed various factors in connection with the possible transaction and why the sale of the Company at the best possible
price was in the best interests of the Company&rsquo;s stockholders. The Company Board decided not to solicit further alternative
proposals to Parent&rsquo;s proposed offer in light of, among other things, the Company&rsquo;s failure to meet revenue projections
since January 2011 (at least in part due to the strategic alternatives evaluation process that was underway, which made it difficult
to recruit new talent to replace attrition within the business development staff), external forces including uncertainties as to
current federal government budgets and delays in contract awards, and the expressed strong preference of some of the Company&rsquo;s
most significant stockholders to sell the Company over other strategic alternatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On balance, given these factors, the thoroughness
of the evaluation of strategic alternatives over the course of nine months (summarized below), the terms proposed by Parent, the
risks and delays associated with steps that would be necessary to increase the Company&rsquo;s value, and the fairness of the proposed
price, the Board concluded that entering into an Exclusivity Agreement with Parent was in the best interest of the Company&rsquo;s
stockholders. The Board authorized the Company to continue negotiations with Parent with the goals of arriving at a detailed understanding
of the terms of the contemplated transaction, agreeing on an Exclusivity Agreement under which the Company would agree to negotiate
exclusively with Parent, and finalizing as soon as practicable a definitive Merger Agreement relating to the contemplated transaction.
The Board further authorized management and the Company&rsquo;s counsel to enter into non-disclosure agreements with the Company&rsquo;s
major stockholders and discuss the contemplated transaction with them to ensure their support.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On the same date, Parent sent a revised draft
Merger Agreement and Exclusivity Agreement to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 4, 2011, Parent, Sagent, counsel
for Parent and counsel for the Company held a teleconference to discuss elements of the transaction to be addressed before the
parties could proceed. In addition, Parent and the Company entered into the Exclusivity Agreement. At the Company Board&rsquo;s
direction, Sagent informed Party C that the Company had signed an Exclusivity Agreement with another party and that it did not
intend to move forward with Party C. Upon the execution of the Exclusivity Agreement, and from October 20, 2011 through the end
of the following week, Parent conducted in-person interviews and due diligence sessions at the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Simultaneously, counsel for the Company circulated
on October 5, 2011, draft non-disclosure agreements (which also prohibited transactions in the Company&rsquo;s securities) to certain
large stockholders of the Company, and such non-disclosure agreements were negotiated over the course of the following week and
a half. Upon execution of the non-disclosure agreements, the Company and its counsel discussed with each stockholder under a non-disclosure
agreement, at a high level, the proposed transaction with Parent to gauge the support of the stockholder. Because Parent had indicated
that such agreements would be required, representatives of the Company also discussed with the major stockholders execution of
an undertaking agreement pursuant to which the stockholders would agree to tender its shares in connection with any tender offer
by Parent and, if necessary, vote its shares in favor of the proposed transaction. Such major stockholders were Lampe, Conway &amp;
Co., LLC, Revelation Capital Management Ltd., Carl Marks &amp; Co., Inc. and Minerva Group, LP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">In addition to the above major outside stockholders,
Parent required the Company to negotiate stockholder agreements with each of Joel Jacks, Peter Schulte, and Dr. Edward Bersoff,
who are all members of the Company&rsquo;s Board of Directors and also significant Company stockholders. It was anticipated that
these undertaking and stockholder agreements would provide for, among other things, agreement of the stockholders to tender shares
equal to an aggregate of 40% of the outstanding Company common stock pursuant to the tender offer and, if necessary, vote such
shares in favor of the adoption of the Merger Agreement. The stockholder and undertaking agreements (collectively, the &ldquo;<I>Support
Agreements</I>&rdquo;) would terminate in the event the Merger Agreement is terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Counsel for the Company circulated initial
drafts of the Support Agreements to the applicable stockholders shortly after the non-disclosure agreements were executed in early
October. For the duration of October and extending through early November 2011, counsel for the Company facilitated negotiations
and revisions to the agreements from each of the stockholders and their outside counsels, as well as counsel for Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 14, 2011, Dr. Bersoff requested
that the Company Board reach a resolution in relation to authorizing Sagent to prepare a fairness opinion. A conference call of
the Company Board, as well as members of Company management and representatives of Sagent and counsel for the Company, was held
to discuss this issue and others. Sagent reported on the considerable financial diligence-related activity that had occurred, and
counsel for the Company discussed the progress made toward entering into Support Agreements with major stockholders. The Company
Board also discussed transaction structure, including a related top-up option. Upon conclusion of these discussions, the Sagent
representatives were asked to leave the meeting, and the Board discussed whether it was advisable to have Sagent deliver a fairness
opinion for the transaction versus a third party. Following detailed discussion and an analysis of the costs and benefits associated
with such decision, the Company Board determined that, in light of Sagent&rsquo;s deep knowledge of the background and status of
the transaction, as well as the Company and its performance, and its extensive industry knowledge and expertise, it would be preferable
to have Sagent deliver such an opinion, and the Company Board authorized the Company to instruct Sagent to prepare such an opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 15, 2011, counsel for the Company
circulated a revised Merger Agreement to counsel for Parent, primarily inserting language in relation to equity financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 19, 2011, counsel for Parent,
on behalf of Parent, circulated a revised Merger Agreement to counsel for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 21, 2011, the Company Board held
a meeting via teleconference in which members of Company management, as well as representatives of Sagent and counsel for the Company,
participated. The participants discussed the status of the ongoing due diligence by Parent, conversations with major stockholders,
and counsel for the Company responded to inquiries in relation to the status of the Merger Agreement and related legal documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 24, 2011, counsel for the Company
and counsel for Parent negotiated the terms of the Merger Agreement via teleconference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 25, 2011, counsel for the Company,
on behalf of the Company, circulated a revised Merger Agreement to Parent&rsquo;s counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 26-27, 2011, Parent and the Company
held a series of meetings to discuss the Company&rsquo;s operations and integration aspects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On October 28, 2011, the Company Board held
a meeting via teleconference in which members of Company management, as well as representatives of Sagent and counsel for the Company,
participated. Sagent reported on the status of the financial due diligence and other items, and counsel for the Company reported
on the status of the legal negotiations. Members of the Company Board asked a number of inquiries in relation to the reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Also on October 28, 2011, counsel for the
Company provided Parent&rsquo;s counsel with a draft limited guaranty to be entered into between the Company and certain of its
investors. Parent&rsquo;s counsel provided the Company&rsquo;s counsel with a list of open issues on the Merger Agreement. Counsel
for the Company provided Parent&rsquo;s counsel with a response to the list of open issues the following day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On November 3, 2011, Parent circulated a
first draft of its debt and equity financing commitment letters, as well as a revised limited guaranty, to the Company and its
counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On November 4, 2011, the Company Board held
a meeting via teleconference in which members of Company management, as well as representatives of Sagent and counsel for the Company,
participated. Ms. Little discussed certain issues with respect to a government contract that had arisen in the course of due diligence,
and how such issues were being addressed by Company management and counsel. The Company Board also discussed at length the issue
of exclusivity and whether to amend the Exclusivity Agreement. Accordingly, on November 4, 2011, Parent and the Company amended
the Exclusivity Agreement to prohibit the Company from providing notice of termination of exclusivity prior to November 11, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On November 9, 2011, Parent, the Company,
counsel for Parent and counsel for the Company participated in a conference call to discuss the outstanding issues in connection
with the Merger Agreement and possible timing for moving forward with the proposed transaction. The Company also had correspondences
with the other party to the government contract that was highlighted by Parent during the due diligence process to discuss the
potential contract issues raised by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On November 11, 2011, the Company Board,
as well as members of Company management, and representatives of Sagent and counsel for the Company, held a telephonic meeting
to discuss the current status of the negotiations and Merger Agreement. Sagent reported that Parent&rsquo;s due diligence was nearly
complete, and the group discussed an issue with respect to a specific government contract that had arisen in connection with due
diligence efforts. The Company Board was updated on the overall status of the transaction, and discussed possible timing scenarios
and whether to further extend exclusivity, scheduled to expire on the same day. The Company Board expressed concern that the Company
had not received a revised draft of the Merger Agreement from Parent and its counsel since October 25, and determined to approve
an amendment to the Exclusivity Agreement that would prohibit termination of the exclusivity period until November 18, provided
that if a revised draft of the Merger Agreement was not received before 5:00 p.m. on November 15, the Company would retain the
right to terminate the Exclusivity Agreement immediately. The parties never executed the proposed extension to the Exclusivity
Agreement, and the Company thus retained the right under the existing Exclusivity Agreement to terminate such agreement on two
business days&rsquo; notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On November 14, 2011, counsel for Parent
circulated a revised Merger Agreement to the Company and counsel for the Company. On the same day, the Company released its third
quarter 2011 financial results and revised its full year guidance downward. Following the exchange of documentation on November
14, 2011, the parties agreed to suspend further discussion on the Merger Agreement until the matter associated with the contract
issue was resolved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On November 17, 2011, the Company Board,
as well as members of Company management, and representatives of Sagent and counsel for the Company, held a telephonic meeting
to discuss the state and timing of the transaction. Management gave an update on the government contract issue that had arisen
during due diligence, and the Board discussed that Parent and its counsel were delaying other aspects of the transaction until
that issue was resolved. The Board also discussed the possibility of moving in the direction of a long-form merger rather than
the tender offer approach, and whether to extend exclusivity. The Board determined not to further amend the Exclusivity Agreement
and generally determined that no Board action was required, and Company management should continue to resolve Parent&rsquo;s concerns
regarding the one government contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">During the course of the due diligence review
from October to November 2011, as mentioned above, certain documentation issues with respect to a government contract were raised
and addressed by the Company and counsel for the Company. The Company was ultimately able to resolve this issue to the satisfaction
of Parent, but it took a period of time to coordinate with the appropriate parties during the holiday season. As a result, the
negotiation and documentary aspects of the transaction were largely tabled from early November until mid-January, when the government
contract in question was modified. After further diligence during the balance of January and early February, it was determined
that the contract modification resolved the issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On January 23, 2012, the Company&rsquo;s
management hosted Parent&rsquo;s management team to discuss 2011 fourth quarter and year-end results, which were lower than previous
estimates, and provided an updated forecast outlook, which was revised lower from the last financial forecast provided to Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On January 27, 2012, Parent called Sagent
to express concern about several topics, including the financial performance of the Company, and as a result of those concerns,
informed Sagent that it was reducing its offer to acquire the Company to a value of $3.05 per share. Sagent requested that Parent
increase its offer, and Parent then provided indications that it would be willing to provide an offer of $3.10 per share to $3.15
per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12.25pt">On January 30, 2012, the Company Board
and Compensation Committee held in-person meetings to discuss the Company&rsquo;s 2011 results, 2012 budget, and 2012 compensation
for executive officers and directors. Members of Company management, and representatives of Sagent and counsel for the Company
participated in the meeting as appropriate, with Sagent presenting an update on Parent&rsquo;s revised offer, process timing and
status of the transaction. Sagent reviewed the Company&rsquo;s relative trading performance, and also conveyed Parent&rsquo;s concerns
about a possible transaction which included the Company&rsquo;s reduction of forecasted fiscal year 2011 adjusted EBITDA from $13.4
million to $11.9 million and fiscal year 2012 adjusted EBITDA from $16.1 million to $14.0 million, as well as Parent&rsquo;s ability
to conclude a tender offer process prior to the end of the first quarter of 2012. Among the matters discussed was the possibility
of deferring the pursuit of strategic alternatives until the Company&rsquo;s operations had stabilized. After discussion that included
input from the representatives of Sagent, the Company Board concluded that stabilizing the Company&rsquo;s operations, especially
given the Company&rsquo;s recent performance and current government services market conditions, would require considerable time
and investment. And whether and when a new process would create more value for stockholders was uncertain. Accordingly, following
a briefing by counsel as to the Board&rsquo;s fiduciary duties, the Board instructed Sagent to respond to Parent&rsquo;s position,
including a price range that the Board would likely find acceptable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Later on January 30, 2012, pursuant to the
Company Board&rsquo;s request, Sagent requested that Parent increase its offer price. Parent verbally acknowledged the Company&rsquo;s
request without formally agreeing to increase its offer to $3.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On January 31, 2012, counsel for the Company
circulated a revised Merger Agreement and issues list to counsel for Parent, picking up from the document last circulated on November
14, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 1, 2012, the Company&rsquo;s
counsel provided Parent&rsquo;s counsel with a draft of the Company disclosure letter to the Merger Agreement. Parent&rsquo;s counsel
provided Company&rsquo;s counsel with a list of open issues on the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Beginning on February 2, 2012 and for the
following two weeks, counsel for the Company, counsel for Parent, Lampe, Conway &amp; Co., LLC, Revelation Capital Management Ltd.,
Carl Marks &amp; Co., Inc. and Minerva Group, LP, and their counsels, as applicable, recommenced negotiations and finalized the
substance of the outside Support Agreements, which had previously halted in November. During that same timeframe, the parties held
negotiations concerning the Merger Agreement issues list and arrived at preliminary agreement on those issues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 3, 2012, counsel for Parent conducted
a conference call with counsel for the Company to further discuss the government contract issue that had been identified during
due diligence. On the same date, a draft of the Merger Agreement and a summary term sheet were distributed to the Company Board
for consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Late on the evening of February 3, 2012,
counsel for Parent circulated a further revised Merger Agreement to the Company and counsel for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 4, 2012, Parent circulated then
existing drafts of its financing commitment letters, which then included mezzanine financing, to counsel for the Company. The Company
and its counsel provided comments to the financing documents and limited guaranty throughout the negotiation process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 5, 2012, Company management circulated
to its Board a memorandum from counsel for the Company describing differences between the draft Merger Agreement circulated to
the Board on February 3, 2012 and the version received from counsel for Parent later on February 3rd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 6, 2012, the Company provided
a revised list of open issues on the Merger Agreement to Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 7, 2012, the Company&rsquo;s
Board convened by conference call to discuss Parent&rsquo;s $3.20 per share proposal and authorized the Company and its advisors,
Sagent and counsel for the Company, to pursue finalization of the transaction documents at that proposed price. The Company&rsquo;s
Board asked Sagent to prepare its opinion with respect to the fairness, from a financial point of view, to the stockholders of
the Company, of the $3.20 per share cash consideration to be offered to such holders pursuant to the definitive agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Later on the same day, counsel for Parent
circulated a revised Merger Agreement to the Company and counsel for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 8, 2012, Parent incorporated
Atlas Merger Subsidiary, Inc. in Delaware, to serve as the merger subsidiary, or Offeror, in the transaction. Also on the same
day, counsel for the Company both provided additional comments to the draft Merger Agreement to Parent&rsquo;s counsel and also
circulated updated individual Support Agreements for Joel Jacks, Peter Schulte and Edward Bersoff to counsel for Parent for review.
Over the course of the remainder of that week and the following week, Company counsel discussed and finalized the individual Support
Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The Company also received due diligence requests
of Parent&rsquo;s lenders, and responded accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 9, 2012, the Company distributed
a revised draft of the Merger Agreement and related documentation, including a revised summary term sheet, all in substantially
final form, to the Company Board. Company counsel also circulated a slightly updated Merger Agreement to Parent&rsquo;s counsel.
Also on February 9, 2012, Parent and the Company met to discuss additional steps to resolve open contract issues raised during
the diligence process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 13, 2012, the Company distributed
resolutions regarding the proposed transaction for the Company Board&rsquo;s consideration. Also on the same day, counsel for Parent
provided Company counsel with comments to the draft of the Company disclosure letter to the Merger Agreement. Throughout the week
of February 13, 2012, Parent finalized its financing arrangements, with Company&rsquo;s counsel reviewing the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 16, 2012, Parent finalized and
executed a mezzanine financing letter with PNC Mezzanine Capital. Counsel to Parent provided Company counsel with a draft of the
Parent disclosure letter to the Merger Agreement. Company counsel provided Parent counsel with a revised draft of the Company disclosure
letter to the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 17, 2012, counsel for the Company
provided Parent&rsquo;s counsel with revised drafts of the Merger Agreement and the Company disclosure letter. On the same date,
Parent&rsquo;s and Merger Sub&rsquo;s respective board of directors unanimously approved the Merger Agreement and the Merger with
an offer price of $3.20 per share. Parent also finalized and executed a debt financing letter with certain lenders and the equity
commitment letter with investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">On February 18, 2012, the Company distributed
a final form Merger Agreement and draft Schedule 14D-9 to the members of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The Board of the Company met on February
20, 2012, and the Company Board engaged in a thorough review, with representatives of Sagent and counsel for the Company, of key
provisions of the transaction and Merger Agreement. Representatives of Sagent and counsel for the Company responded to detailed
questions from members of the Company Board regarding the Merger Agreement and the transaction generally. Once again the Board
discussed the possibility of deferring the pursuit of strategic alternatives until the Company&rsquo;s operations had stabilized.
The Board discussed extensively the Company&rsquo;s recent performance, including downward revisions to its projections and guidance
during the strategic evaluation process, the Company&rsquo;s likely future performance, taking into account the uncertainty and
negative trends in federal and other government spending, and that the government services sector stock trading performance has
been worse during recent periods than broader market indices, with the Company&rsquo;s stock performance likely being affected
by speculation concerning the outcome of the Company&rsquo;s assessment of strategic alternatives. The Board had followed closely
the strategic alternatives evaluation process over the past year and the extensive auction process conducted by Sagent and Company
management during that time. Once again, after discussion, the Company Board concluded that stabilizing the Company&rsquo;s operations,
especially given the Company&rsquo;s recent performance and current government services market conditions, would require considerable
time and investment. In these circumstances, the Board concluded that providing near-term liquidity for stockholders in the proposed
transaction was in the stockholders&rsquo; interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Sagent presented its analysis of the Offer
and the Merger and delivered an oral opinion, subsequently confirmed in writing, that, as of that date and based upon and subject
to the assumptions, factors and qualifications set forth in the written opinion, the $3.20 per share cash consideration to be offered
to the holders of shares of Company Common Stock in the Offer and the Merger is fair to the holders of shares of Company Common
Stock (other than Parent, Merger Sub, the Company and holders who are entitled to and properly demand an appraisal of their shares
of Company Common Stock) in the Offer and the Merger was fair from a financial point of view to such stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Representatives of Sagent responded to numerous
questions from members of the Company Board regarding its financial analyses of the Company and the Offer and Merger. Among other
things, the discussion encompassed the selected precedent transaction analysis, it being noted that most of the transactions cited,
with two exceptions, dated back to 2010 when government sector valuations were more robust. The Board was aware of and considered
the effects of the &ldquo;Base&rdquo; and &ldquo;Adjusted&rdquo; forecasts discussed below on the Sagent discounted cash flow analysis
and, in that context, took into account the Company&rsquo;s recent performance and federal, state and local government spending
trends. The Board considered the steps needed, cost involved, and length of time it might take for the Company to stabilize and
improve its revenue and operating results. In the context of considering the Sagent fairness analysis, the Board took into account
all of the considerations and reasons for a determination that the sale of the Company at the proposed price is the best strategic
alternative for the Company&rsquo;s stockholders; such factors are summarized below under &ldquo;&mdash;<I>Reasons for Recommendation</I>.&rdquo;
After further discussion, the Company Board unanimously approved the proposed Merger Agreement, Support Agreements, Offer and Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The Company Board also approved a cash bonus
for <FONT STYLE="color: black">each of Ms. Little and Mr. Hassoun equivalent to four months&rsquo; base pay paid upon the closing
of the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Following the approval of the transaction
by the Company Board, the Merger Agreement, Support Agreements and other transaction-related documents were signed and, on February
21, 2012, the Company and Parent issued a joint press release announcing the execution of the Merger Agreement. A copy of the joint
press release issued by the Company and Parent has been filed as Exhibit (a)(8) and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt"><I>Summary of Third Party Contacts</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The following table summarizes the contacts
made by Sagent, at the request of the Company Board, to evaluate third party interest in acquiring the Company.</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="background-color: #CCCCCC; padding-right: 0; padding-left: 0; font-weight: bold">Number of Parties</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%; border-bottom: windowtext 2.25pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Event</B></P></TD>
    <TD STYLE="width: 15%; border-bottom: windowtext 2.25pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Strategic</B></P></TD>
    <TD STYLE="width: 15%; border-bottom: windowtext 2.25pt solid; padding-right: 0; padding-left: 0; font-weight: bold">Financial Sponsor</TD>
    <TD STYLE="width: 15%; border-bottom: windowtext 2.25pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Total</B></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Sagent Contacted Initially</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">64</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">35</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">99</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Sagent Sent &ldquo;Teaser&rdquo; Information</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">62</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">33</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">95</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Sagent Sent Non-Disclosure Agreement (&ldquo;NDA&rdquo;)</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">23</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">25</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">48</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Signed NDA / Sagent Sent Confidential Information Presentation</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">13</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">21</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">34</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Sagent Sent First Supplemental Information Packet</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">7</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">12</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">19</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Submitted Indication of Interest</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">3</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">4</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Sagent Reached Out Again in July After Third Party Initially Declined</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">3</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">8</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">11</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Sagent Sent Second Supplemental Information Packet</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">2</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">6</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">8</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Management Presentation</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">3</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">4</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Sagent Sent Third Supplemental Information Packet</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">Detailed Program Review Presentation</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-bottom: windowtext 1pt dotted; padding-right: 0; padding-left: 0; font-weight: bold">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: windowtext 1.5pt solid; padding-right: 0; padding-left: 0">Submitted Final Offer</TD>
    <TD STYLE="border-bottom: windowtext 1.5pt solid; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-right: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 0; padding-left: 0">1</TD>
    <TD STYLE="border-bottom: windowtext 1.5pt solid; padding-right: 0; padding-left: 0; font-weight: bold">2</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt"><I>Reasons for Recommendation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">In evaluating the strategic alternatives
available to the Company, and specifically the Merger Agreement, the Offer, the Merger and the other transactions contemplated
by the Merger Agreement, the Company Board consulted with the Company&rsquo;s senior management, legal counsel and an independent
financial advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">In determining that the sale of the Company
at the proposed price is the best strategic alternative for the Company&rsquo;s stockholders, the Company Board considered a number
of factors, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 3%; padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 93%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">improving the Company&rsquo;s revenue and operating results would require investment in the business, and in the current market climate such investment would not likely have the support of the Company&rsquo;s most significant stockholders, who have expressed a strong preference for selling the Company over other strategic alternatives;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">since January 2011, the Company has failed to meet revenue projections and reduced its 2011 financial forecast on six occasions due to a number of factors, including uncertainties as to federal government budgets and government spending reductions,&nbsp; a slowdown in government procurement, related delays in contract&nbsp; awards, and the Company&rsquo;s inability to attract and retain senior staff given the uncertainties caused by the pendency of the strategic alternative assessment process;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">there is a very good chance that federal, state and local government spending may at best remain steady, and likely shrink;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">given the special issues surrounding the U.S. housing market and government-sponsored enterprises such as Fannie Mae, it is not surprising that the Company&rsquo;s revenue from Fannie Mae has been on a downward trend;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the factors contributing to the Company&rsquo;s failure to meet financial forecasts are still present, and the risks associated with achieving future forecasts are high;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">notwithstanding disappointing revenue trends,&nbsp; the Company&rsquo;s current EBITDA margins and backlog make it attractive to potential buyers;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">if the Company Board decided to abandon the assessment of strategic alternatives, the Company&rsquo;s EBITDA margins and backlog would likely shrink at least in the short-term;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the Company Board has been very closely involved in reviewing the sales process, with regular (often weekly) updates from management and representatives of Sagent;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 3%; padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 93%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">abandoning the strategic alternatives process in favor of stabilizing and then improving Company performance would involve considerable time and investment;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">due to factors outlined above, the government services sector is under pressure, and there can be no assurance that a better valuation could be achieved following stabilization of, and investment in, the Company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">a sale at this time will provide immediate liquidity to the Company&rsquo;s stockholders; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">as long as the Company&rsquo;s evaluation of alternatives remains unresolved, it will be increasingly difficult for the Company to recruit high caliber personnel to fill key operating, sales and development positions.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">In recommending that the Company&rsquo;s
stockholders accept the Offer, tender their shares of Company Common Stock to the Offeror pursuant to the Offer and, if required
by applicable law, vote their shares of Company Common Stock in favor of adoption of the Merger Agreement, the Company Board also
considered a number of other factors, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 3%; padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the Company Board&rsquo;s knowledge of the Company&rsquo;s business, financial condition, results of operations, prospects and competitive position, which were based upon the Board members&rsquo; close monitoring of the Company&rsquo;s performance and strategic alternative evaluation efforts through regular (often weekly) conference calls and discussions with Company management during the course of the process, coupled with the Board members&rsquo; (i) experience in the government services sector including service on boards of other publicly-held government services companies such as ICF International, Inc., Sparton Corporation and Science Applications International Corporation; (ii) tenure within government departments such as the U.S. Navy and U.S. Department of Defense; (iii) leadership of other public companies within the industry in the roles of president and chief executive officer; and (iv) experience in the accounting, capital markets and private equity sectors.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the Company Board&rsquo;s belief that the Offer and the Merger are more favorable to the Company&rsquo;s stockholders than any other strategic alternative reasonably available to the Company, including continuing as a stand-alone entity, with the reasons for such belief outlined in the bullets above, including, but not limited to, (i) the Company&rsquo;s failure to meet revenue projections and reductions to its 2011 financial forecast on six occasions due to a number of factors, including a slowdown in government procurement; (ii) improving the Company&rsquo;s revenue and operating results would require considerable time and&nbsp; investment in the business, and in the current market climate such investment would not likely have the support of the Company&rsquo;s most significant stockholders; and (iii) there is a very good chance that federal, state and local government spending may at best remain steady, and likely shrink;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Offer is the result of a comprehensive auction process conducted by the Company involving outreach to a large number of both potential strategic and financial purchasers, with such outreach involving a significant number of management presentations and an extended diligence process;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Offer provides for a cash tender offer for all shares of Company Common Stock held by the Company&rsquo;s stockholders to be followed by the Merger, which allows the Company&rsquo;s stockholders to quickly realize a fair value, in cash, for their investment and provides stockholders certainty of value for their shares;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0"><FONT STYLE="color: black">the presentation by </FONT>Sagent<B> </B><FONT STYLE="color: black">on </FONT>February 20, 2012 <FONT STYLE="color: black">to the Company Board, together with its written opinion dated February 21</FONT>, 2012<FONT STYLE="color: black">, that, as of such date and based on and subject to the factors, assumptions, qualifications and limitations set forth in the opinion, the $3.20</FONT><B> </B><FONT STYLE="color: black">per share cash consideration to be offered to the holders of shares of Company Common Stock (other than Parent, Merger Sub, the Company and holders who are entitled to and properly demand an appraisal of their shares of Company Common Stock) in the Offer and the Merger is fair, from a financial point of view, to such holders. The full text of </FONT>Sagent&rsquo;s<FONT STYLE="color: black"> written opinion, dated February 21, 2012, is attached hereto as Exhibit (a)(7);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the Company Board&rsquo;s belief that the terms of the Merger Agreement, including the parties&rsquo; representations, warranties and covenants, and the conditions to their respective obligations to consummate the Offer and the Merger, are reasonable and are the product of arms&rsquo; length negotiations between the Company and its advisors, on the one hand, and Parent and its advisors, on the other hand;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 3%; padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Offeror must extend the Offer for up to two consecutive periods of five business days each, if, on any then-scheduled expiration date, any of the conditions to the consummation of the Offer is not satisfied and has not been waived;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the potential for closing in a relatively short timeframe provided by the structure of the transaction could reduce the amount of time during which the Company&rsquo;s business would be subject to the potential uncertainty of closing and related disruption;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Company Board would be permitted, in accordance with the terms of the Merger Agreement, to authorize the Company to provide information to, and engage in discussions or negotiations with, a third party following the receipt of a bona fide written alternative acquisition proposal that the Company Board determines in good faith, after consultation with outside legal counsel and the Company&rsquo;s independent financial advisor, constitutes or could reasonably be expected to lead to a superior proposal;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that, subject to compliance with the terms and conditions of the Merger Agreement (including provisions regarding notification to Parent of certain matters, provisions regarding further negotiations with Parent and provisions regarding payment of a $1.5 million termination fee plus expenses of up to $1 million), in certain circumstances, the Company may terminate the Merger Agreement in connection with a determination by the Company Board to enter into a superior transaction with a third party;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the Company Board&rsquo;s belief that the termination fee of $1.5 million plus expenses of up to $1 million would not be a significant deterrent to competing offers and that the amount of such fee and expenses is believed to be within the range of termination fees payable in comparable transactions; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the availability of appraisal rights of holders of shares of Company Common Stock who comply with all of the required procedures under Delaware law, recognizing that a condition to the Merger is that holders of not more than 10% of the outstanding shares have exercised appraisal rights.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The Company Board also considered a number
of uncertainties and risks in its deliberations concerning the Offer, the Merger and the other transactions contemplated by the
Merger Agreement, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 3%; padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the potential disruption to the Company&rsquo;s business that could result from the public announcement and pendency of the Offer, the Merger and the other transactions contemplated by the Merger Agreement, including the possible diversion of management and employee attention, potential employee attrition and the potential effect on the Company&rsquo;s business relationships;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the possibility that the Offer, the Merger and the other transactions contemplated by the Merger Agreement might not be completed in a timely manner or at all due to the necessity of receiving approvals under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and any other applicable antitrust or national security laws and regulations;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Offeror is not obligated to purchase any shares of Company Common Stock in the Offer unless, among other things, at least 75% of the outstanding shares of Company Common Stock (determined on a fully diluted basis) have been validly tendered and not withdrawn in accordance with the terms of the Offer and certain regulatory approvals are received;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that an all-cash transaction will be taxable to the Company&rsquo;s stockholders for U.S. Federal income tax purposes;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Company&rsquo;s stockholders will not participate in future growth of the Company and will not benefit from any appreciation in value of the combined company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Merger Agreement contains contractual restrictions on the conduct of the Company&rsquo;s business prior to the completion of the transactions contemplated by the Merger Agreement;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that the Merger Agreement contains a termination right in the event that Parent is unable to obtain debt financing; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 3%; padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">&bull;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">the fact that, subject to the limitations set forth in the Merger Agreement, the Company could be required to pay a termination fee of $1.5 million plus expenses of up to $1 million in connection with the termination of the Merger Agreement under specified circumstances involving competing transactions or a change in the Company Board&rsquo;s recommendation to the Company&rsquo;s stockholders, as well as the potential for such termination fee to discourage third parties from proposing a competing business combination transaction after the Merger Agreement was signed.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The Company Board believed that, overall,
the potential benefits of the Offer and the Merger to the Company stockholders outweighed the risks and uncertainties of the Offer
and the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The foregoing discussion of information and
factors considered by the Company Board is not intended to be exhaustive. In light of the variety of factors considered in connection
with its evaluation of the Offer and the Merger, the Company Board did not find it practicable to, and did not, quantify or otherwise
assign relative weights to the specific factors considered in reaching its determinations and recommendations. Moreover, each member
of the Company Board applied his or her own personal business judgment to the process and may have given different weight to different
factors. In arriving at their recommendation, the members of the Company Board were aware of the interests of executive officers
and directors of the Company as described under &ldquo;<I>Arrangements with Current Executive Officers and Directors of the Company</I>&rdquo;
in Item 3 above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">ITEM 8.</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0; font-weight: bold">ADDITIONAL INFORMATION.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Item 8 of the Schedule 14D-9 is amended to
include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt"><I>Legal Proceedings</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt"><B>&#9;</B>Two putative class action lawsuits
have been commenced against the Company, Offeror, Parent and current members of the Company&rsquo;s Board (the latter, the &ldquo;<U>Individual
Defendants</U>&rdquo;). One lawsuit was filed in the Court of Chancery of the State of Delaware (the &ldquo;<U>Delaware Suit</U>&rdquo;)
and the other lawsuit was filed in the United States District Court of the Eastern District of Virginia (the &ldquo;<U>Virginia
Suit</U>&rdquo;; together with the Delaware Suit, the &ldquo;<U>Class Actions</U>&rdquo;). The Class Actions seek certification
of a class of all holders of the Company&rsquo;s common stock and variously allege, among other things, (1) the Individual Defendants
have breached and continue to breach their fiduciary duties of undivided loyalty, independence or due care with respect to plaintiff
and other members of the class in connection with the proposed merger, (2) the Individual Defendants failed to properly value the
Company, take steps to maximize stockholder value and avoid competitive bidding and gave Parent an unfair advantage, and have not
made all necessary disclosures concerning the transaction, and (3) the Parent and Offeror aided and abetted the alleged breaches
of duties by the Individual Defendants. The Class Actions seek, among other things, an injunction prohibiting consummation of the
merger, attorneys&rsquo; fees and expenses and rescission or damages in the event the proposed transactions are consummated. The
Company believes the Class Actions are entirely without merit and intends to defend against them vigorously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Also, Item 8, &ldquo;Forward-Looking Statements,&rdquo;
is amended to state as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">Statements in this Statement may contain,
in addition to historical information, certain forward-looking statements. All statements included in this Statement concerning
activities, events or developments that the Company and Parent expect, believe or anticipate will or may occur in the future are
forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ
materially from those indicated by such forward-looking statements as a result of various important factors. Forward-looking statements
are based on current expectations and projections about future events and involve known and unknown risks, uncertainties and other
factors that may cause actual results and performance to be materially different from any future results or performance expressed
or implied by forward-looking statements, including the risk that the tender offer will not close because of a failure to satisfy
one or more of the closing conditions and that the Company&rsquo;s business will be adversely impacted during the pendency of the
tender offer. Additional information on these and other risks, uncertainties and factors is included in the Company&rsquo;s Annual
Report on Form 10-K filed with the Securities and Exchange Commission on February 17, 2011. In addition, the forward-looking statements
included in this Statement represent our views as of March 9, 2012. Subsequent events and developments may cause our views to change.
However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any
obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent
to March 9, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt"><BR CLEAR="ALL" STYLE="mso-special-character: line-break; page-break-before: always">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0; font-weight: bold">ITEM 9.</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; font-weight: bold">EXHIBITS.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">The following Exhibits are filed herewith
or incorporated herein by reference:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 12%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 80%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP COLSPAN="6" STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0; font-weight: bold">Exhibit No.</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0; font-weight: bold">Description</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(1)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Offer to Purchase, dated February 28, 2012 (incorporated by reference to Exhibit (a)(1)(A) to the Schedule TO of Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. filed with the Securities and Exchange Commission on February 28, 2012 (the &ldquo;<I>Schedule TO</I>&rdquo;)).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(2)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Letter of Transmittal, dated February 28, 2012 (incorporated by reference to Exhibit (a)(1)(B) to the Schedule TO).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(3)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Notice of Guaranteed Delivery (incorporated by reference to Exhibit (a)(1)(C) to the Schedule TO).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(4)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees (incorporated by reference to Exhibit (a)(1)(D) to the Schedule TO).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(5)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees (incorporated by reference to Exhibit (a)(1)(E) to the Schedule TO).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(6)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Option Notice and Cancellation Agreement (incorporated by reference to Exhibit (a)(6) to the Company&rsquo;s Schedule 14D-9 filed with the Securities and Exchange Commission on February 29, 2012)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(7)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Opinion of Sagent Advisors Inc., dated February 21, 2012 (incorporated by reference to Exhibit (a)(7) to the Company&rsquo;s Schedule 14D-9 filed with the Securities and Exchange Commission on February 29, 2012)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(8)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Joint Press Release issued by ATS Corporation and Salient on February 21, 2012 (incorporated by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(9)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Salient-ATSC Transition Help Q&amp;As, dated March 6, 2012 (incorporated by reference to Exhibit (a)(9) to the Company&rsquo;s Amendment No. 1 to Schedule 14D-9 filed with the Securities and Exchange Commission on March 6, 2012)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(10)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Complaint filed on March 2, 2012 in the Court of Chancery of the State of Delaware, captioned Stourbridge Investments LLC, individually and on behalf of all others similarly situated v. Edward H. Bersoff, Kevin S. Flannery, John H. [sic] Schulte, Edward J. Smith, Anita K. Jones, Joel R. Jacks, James R. Swartwout, ATS Corporation, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (Case No. 7300)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(a)(11)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Complaint filed on March 6, 2012 in the United States District Court of the Eastern District of Virginia, captioned Giancarlos Guerra, on behalf of himself and all others similarly situated v. ATS Corporation, Edward H. Bersoff, Kevin Flannery, Joel Jacks, Anita K. Jones, Peter Schulte, Edward Smith, James R. Swartwout, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (Civil Action No. 1:12 CV 244)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(1)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Agreement and Plan of Merger, dated as of February 21, 2012, by and among Salient Federal Solutions, Inc., Atlas Merger Subsidiary, Inc. and ATS Corporation (incorporated by reference to Exhibit 2.1 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(2)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Stockholders&rsquo; Agreement, dated as of February 21, 2012, by and among Joel R. Jacks, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (incorporated by reference to Exhibit 2.2 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(3)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Stockholders&rsquo; Agreement, dated as of February 21, 2012, by and among Peter M. Schulte, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (incorporated by reference to Exhibit 2.3 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; width: 12%">(e)(4)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; width: 80%">Stockholders&rsquo; Agreement, dated as of February 21, 2012, by and among Dr. Edward H. Bersoff, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (incorporated by reference to Exhibit 2.4 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(5)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Undertaking Agreement, dated as of February 21, 2012, by and among Lampe, Conway and Co., LLC, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (incorporated by reference to Exhibit 2.5 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(6)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Undertaking Agreement, dated as of February 21, 2012, by and among Revelation Capital Management Ltd., Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (incorporated by reference to Exhibit 2.6 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(7)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Undertaking Agreement, dated as of February 21, 2012, by and among Carl Marks &amp; Co. Inc. and other parties, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (incorporated by reference to Exhibit 2.7 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(8)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Undertaking Agreement, dated as of February 21, 2012, by and among Minerva Group, LP, Salient Federal Solutions, Inc. and Atlas Merger Subsidiary, Inc. (incorporated by reference to Exhibit 2.8 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 21, 2012).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(9)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Confidentiality Agreement, dated as of March 31, 2011, between Salient Federal Solutions, Inc. and ATS Corporation (incorporated by reference to Exhibit (d)(11) to the Schedule TO).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(10)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Exclusivity Agreement, dated as of October 4, 2011, between Salient Federal Solutions, Inc. and ATS Corporation (incorporated by reference to Exhibit (d)(9) to the Schedule TO).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(11)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">First Amendment to Exclusivity Agreement, dated as of November 4, 2011, between Salient Federal Solutions, Inc. and ATS Corporation (incorporated by reference to Exhibit (d)(10) to the Schedule TO).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(12)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Employment Agreement, dated September 2, 2010, between ATS Corporation and John Hassoun (incorporated by reference to Exhibit 10.16 to the Company&rsquo;s Form 10-K for the fiscal year ended December 31, 2010).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(13)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Employment Agreement, dated February 3, 2008, between ATS Corporation and Pamela A. Little (incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K filed February 6, 2008).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">(e)(14)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 6pt; padding-left: 0">Bersoff Agreement between Dr. Bersoff and the Company dated December 15, 2010 (incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Form 8-K on December 16, 2010).</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
</TABLE>
<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 12pt">After due inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this Statement is true, complete and correct.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 10%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ATS Corporation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">By:&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0; border-bottom: Black 1pt solid">&nbsp; /s/ Pamela A Little</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Name:&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Pamela A. Little</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Title:&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Co-Chief Executive Officer and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March 9, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>seal.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 seal.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`!9`%,#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^^BG;3N1<
MJ0X8Y4DL"HS@K@?0G=P>U,8JI&]E10,R,QP%W8\L+Q\[/D9&5V_[5?'?[2?[
M2[_#B\TWX2?#S2=0\4?';Q]I^MCP9H.DV-]>6VGG3=-:^:Y\0ZI96&H6VB75
MT<2Z597R1M?VG^FF:V4JA`/1?C)^TG\,_@BNF6/BK5/M'BG7"\6C^%-*#7NK
MM/-!?R:5/JUM;QRWNBZ)J5U8/IZZ]<6,MA%=NJJ9U`9OEW_A,OVK_CKIVI:M
MHS>'OV=/AVVM)_8.M^)KNZTCQ/JND7,_FL]]#]BNH+?5+?3CY@$-Q-8:E>1R
M+%=6D3&9/G;5?#&@_LN7GB?XY_%R[U'XV_%QKG1]&^,'Q=UA;74?@Q\!-#U?
M4-3FT34?&6FMJ(UNP\,^"O[3L+WQ1HUA=:A'INDZE;>(;<M:Q)`_UU\:_!WQ
M)\6?%CP#XTT>_'C/]GCQ%\$_'GPZ\4^%?#-S<7<^B>+?%MGI/B#P3\7M/A5K
M>P?2;6PTV]T5+BU"/:PZE::K%<,S1Z>X!SNE_"E-:\07/@#7?VK_`(Q>*?'N
MCW=E:^)++PT8VM?">KW>DQZ]8:9K3P:/?VU@+[3&>YM9+Z^B;8FQU+98/G^'
MVAZ[XOO_``1X<_:H^+,NM^&-9BT+6;-FTS6;/3_&+Z>^M?\`",7FI6]I9V5M
MXADT=&UA-(GN56/3LR7%W"5('S=^R+X%L_V3OB5K_B;]H3]IKP1XL\;?$/X5
M?LZ^%9]-L_%^K:EJL_Q#^$OPXU/PQ\0O$WBW8NGV6KG5M+.FW=EK%[:Q/J,Y
MDD;S9V4MZ5<WUKHJ?M'^#?A+^TM\`SK?[0WB7Q5XP^&5KXYNWA\3>$/&7B3P
MP^E>*[=9-.2'^T+6.+3M?G\.7;6KW<MN(K."5X/G<`]%T&?]J/P?]F\1>#?B
M'X._:'^'VIV"ZY9V\>IMJ.N7>B7TLLFB7&CV]O8I%?Z?J%H;00ZA97;VOVB6
M2&$SI`)I/>?A]^T_X(\6:_'X%U^QU/P#X[AGCTZZ\.^)K>WTK-\-)BU:1K#S
M;HO-IS6\BBWE17>-F2"Y2*0-C\]9-'^+7[)EY^TE\9['1-8U;P1\,/V4/"'P
MW^!D]W=M=^!_#7AGX$>!=8\??$3QEKEC$^D*/[0\9:I#;^&M,^QV5SK-OHQT
MU)K3,EO:^J:'\4/A+\=/A]^RCX<^.$,J?%WX[_`O3OB1;?%'P%!I>AV?A34X
MO`^C_$W6[6'Q!J,UW?>'+[Q+X<O(+RQLM2MKJQO]+$\2:F)6CN)`#]40K''R
M,AVACYA0``CD;HWERPY!`XXR#@@EH.1D9P>1D$'GU!Y!]0>1T-?#_P`+/BA\
M0_AGXEO_`(9?M&ZWX1FTJ]":G\,?B=HS2:5H?B^R2VCU*[MI+G4Y(+:'4=.L
M)K9YVAEO+:[E>0130QXW?;L<L5Q'%/!+%,ES$EQ;M'+'(L\,JB1)(Y(B\4BL
MC!E>)GC<$,C%2#0!?B_U:_C_`.A&BB'F-3SSGJ,'J>H['VHH`\C^+7Q'TWX7
M?#KQ7XRU.6S6/1K&_%A'>7=I:0WOB"6!I=%L/MM_)!9V<D\S)$'OY+>SC.TR
M7:H5>OS?^!FC/I'B>'XF_$?4?#.O_M*?M#IKGB;P'X=M]2T#P_X\T7X;:;';
M0^/;GPU<02:SX>\4ZMX.T^9'T'6](.IZ7J6FR00V&KZA9M'JUUL_MM:7I?[2
MWQM^!G[*,.L:Q8Z=HWB_0OB]\1[G2/\`A#M<LKG0]!U"40>'-0TGQ(-2O[?[
M0$W37>E65I<6/FLL<L@VJGE/Q-\->'?V@/CCX/\`"FF?%WP;?1_"OXOZ;X%?
M]FO4],7X<?&[X*_\(MYV@:)\=O@9\2=#U33OB/+K=AIMOINI)>7%E-X2\2^#
M]5DT^35-'@LU:\`.8_9V^#OQL\&:_P#%2Z^)GQH\):K^SYKFOZMX<\0V>O\`
MP:\"6\'[4/PYU'PQJ'A_PUI$FJ2ZIH.NZ)\9O"^HW-W\,_B?K.J66JVGC2TT
M[0O[*M+>6[@GB^T(?AKXF^,'PKL]'UE-;^'7P-TJS\.VWPR\`^!]=U[PGXQO
MM$\/2Q2^%;G6O%%U)/JEKIMUHMKH]O>^&-5TAKFWCBN[6\OI)9I?*Q;FX^%V
MF^&O'/QV\6:A<>(O@M\`=,\0>(O">C?N?$U[XB?PII,^H^//%6L^9/=S^(_$
M.H>)8KJ>VT^>VLC8ZE:6NIZ;<M]C-J>FT7]K;QGX?\#OXJ^,/P?U*33ELK/4
M_MOPEO+7QIIFJ:%X@<MIP3P]?3:?XN&LV]HT4FKZ?-IY^QW!FM5N[UHVFD`/
MAK_@H!I&L_!?]F3PYXG^'-MX3^%>D0>*KFY^.?QGATS0[;Q'X9TOPUKNEP^%
M-/F\7"P>]N[G5;Z5-#2&TBU&_P!84J;B2W>YEC/7?\$S=5\1_&CX$Z=??&S0
M--\>7,&B76IZCXC^(7AC3;_Q'J4VK3>([K0M:_LW45O]>TJ9].GFA73;+[*]
MJ;UTB$'E-;/UW[0]QI/_``4"_91\>_!?X)_#7Q+J*^.[;0#I6@?$_1[_`,!^
M"[:X\(>.+'6]5@\5+?)=ZK8:?K$MC)90WMEI\>J%"ES%.LP\JLW]FCP7XL_8
M"@\5M\6/A/X/\.>#_&,_A_3=)U?]G.7QQXX\.Z='INEW=_J46MCQ=<7?BW2+
MBSU'49M*T^$E[74[/3SJPUB*21[.$`]XT?\`9[\6V6A:EXE^&336-[J_AV%=
M4\"^,=0U/6OAQ\0C:WFHZE=Z/<_#[7I8T\.%=6U:[%Q<M=7<-]9QV]@^C621
M*D?S;^TGX6U;4?!/AWXU_`7P]I.C_&S]G.Q\8>#[3X"^(M(_M'P=#\3/BCJO
MAGPI-KGBZ*5-%;Q)X`^'?AJ'Q??^$]/LH--T.>"WL+6T_LK38$@'WKXB_:U^
M%=OI^DVVB/XBUW5?%UA8#PJ^CZ1+_P`3%=;*2VTMKJ6J75C;1K;+>:<M_<F>
M:+[7J%I'Y\N\S'Q:[\0>-/%7P\_X:$M/#CV/Q9^'^MZWX8\4^$='ECOKGQ#\
M/;?7]3\.7NC>)3/!=Z?J?B;1M-EN=1EN[:RFAL[H2V<#2PB.\(!N_$/X82>(
M/"WA_P""OQ#^,D?B_P")6O:%<7_PC^(^LW7@_P`/^)M=\8Q6=[?^+X=(\/>'
M+6SN/[$N=&TZWE6YM8?LMN+K^S4EG%O;S3>M_LM_&&;Q_P"'KWPIXBO(+OQI
MX%GBLM32`,RV]B'N=.MHKV[E82G4K>[TZ_M+^*2'SE:W@EE;-XB1?FMXR\1_
M`[X&?$]OBG!\)OB#XZ^(?[3%GI>D?"[XN7FN6ND>&=6T_3?$%OKN@>"_B9X\
M\4WVD^&/@&G@S53J7A[P]IGA"YEU+Q3X5TU+O44G>,V:_0P\1Z)\+OC?\)?V
M@K+[+'\.OVI/"EAH'B33O"<<GB+29/BCXJFLM0NM<MM5L9(5U?3M6BM'O;+6
MK?3+2SN4M+J]MR\6KC[.`?JQ#S&I^89SPPPW4_>'.&]1V-%+'DH"<9RV<9QG
M<<XS@XSTR`?6B@#\:/AA?:K\6OVXOVMO$?A@VMUJW@_X8^(?AMX:N$U6[@M4
M\10ZK!I5OI&IZU9@1Z>_VV.Y22VM;V#4M+CC23R&E81I)XL\>_$GP]X1\6?'
M;5_V8I/@WK_P<^&&L?"M]0\10^%_$GC'XJ>(O%5YX+\,Z"/AKX\,S>*]2^'N
ME/#K$D%YXMUO0=8U&&_L-0@L(TM;BRDI?\$^]#N-'_:R_;@BBOK.ZLKGXG^-
MK^>[@BEGUR'7KWQI$DENVJ1M:^%XK%;!8K6'1IM(N-?LY8W-WKE[<M*S_;7[
M84!NOA+;QSZ=;7^F+\3OA/\`V]87EN9(GTP^-O#T=X+:*SCE\N5;:[\]9KV+
M7)K%[3-EHU]`\5]"`?`7Q2UOX;:)\`OVC/V=[3QIHNH>,?#'P#^(GA=OAOH>
MNQW_`(U\4)_PB^D_$?Q%XE;1M)L;6[\BT\1ZIK^C:#K=U-ILC6,MG:S6T\TD
MVS9D^$6O_'3XBZ+X]^)\3:M^SQ\-O`^ACX>^!-7U>Y?PGXF\2Z;H*ZO:^.;_
M`$6[DTT3W,<HBDM;^QN;:21F%Y)=2EME?%7PTT;2?!7_``4;\,_#SXA^,->\
M%^&/B#X6\<>`_!7AKQ/HUIJ7QE^.?Q!7XAZ]JNLZ!>_$S0-'N=.U_P"%F@?#
MSQGKGB.RTMYK#6]"\/Z1H.FZTT]QX>:[O/N_X6_#'X30:MXJBUCX:^)O$_BO
M3]$O_!6EV5L5U#1Y+TZ/K4#OI^BZQJL=D8[--&EMYIC=*(GN;"*&.<7<1`!Z
M%^Q!\<;7QO\`#7QEI6LQ^'K&]L)8KS3]0T?5+F[?Q?J'B>Z\;:_-H$<IO=3U
M>^O_``Z--CT_68[1[6*UF>;[.TT,0:3N_`?Q!>\^$_P5^'7CF^\&:K>^++>Y
M\/?$:UCUS5)M9TF!],NK_2KG2+J\^PW_`-MTI%M[1KC4I#-#9Q"&73TD#(OX
M^_$CX7?MH^'?#VE:+\*M3_96^!GPY_9[O_!>O17_`(@\$?$2P\<>+;_4O#6M
MZ+IFB3>)?#<%MH]]86&K:S:Z=.(H8FFN\JHN+:3[;6[^SWXX_P""B\WB32=7
M\;Z[^SOXG\1?'35/"NI>#]+O_"'Q%TRT\,1Z)X$O+OQ3X1TS1-/O-7DMO%]A
MH^EQ^(-8UP:C_86KV>JK'X>EU?7K>ZT",`_4;PKX*TG6?@5IMCJOA/4]<U_Q
M-X*^'/@;6+RSM?+;0_"&KZ/9RWGBWP+<SR+96Y<RW.N&_L%@DVMH_P#HT*Z1
M&ES>^"VMZ=H6B?$"Y@U/4-3M="^,_P`3O".EV45S%_9USX=FL->N8;B:8I'#
M*6T;38]?FU&5L175RUD89/+-S+QOBZ]_9G\!Z#J<WB#6?$NCW/AZSU_X@7&J
M>$/$OB6;0].\6^);%D\1:<EI>7^H2P:;I^I7$UYI>GSVUMIVG65YIUI9I-!Y
M3M^=GQ:O/AMX5G^'7@[6_B!XMTOPJ\>F^,O%FG7OCNV^'FG^.=)/A34+)]2N
M]:N;&ZATZ20^,_#`\2-K8T2;5;^XLM+T.TU%=9BN+0`^Q?"_AC2?B7X1T[PQ
MI/[/5A\=/'/[*GQ*UF#X6:)\6M;TRP\$:#;?%;PY+K.B_$#69/$?_"5IJ\$&
MAZSJ,=AJT/AF^?0Y+^*W\/V-FEA$6O?$?P-\1O"G['FBV_Q(\0:XOQ`^'/QP
M\#>-;E!86^@^%?",6H:K:Q77PV^#0M93?7OPB\'Q:K?>%_A^NJW$&L7'A2TT
MIM0>&[\Q!]/_`++U@A^+_P"TU<2Q^'GN'U'X/Q:C_8>F7R^'S?1_#/2HK`>'
M[/4;<WUMH5O;Q@O&]S"5NU\XPV.9;9<;_@I;+#:_LK:[;7(O66?QM\-(/M-M
M.6FMIY_%]C(+R[D=ED-ND5D?,2W17(G79!&J!"`?;WPWUE?$7P^\$Z\D4D"Z
MQX6T+4?)ECDAEA-WIMO,T4D,L]S+#)&SE'BDN;B2-@4>>9E,C%<Y\#[VSN_A
M!\-[JUGAEM;CPAHLUM+"\CPRV\EI&\$D+31Q3-%)$4>)I8HY"A4O&C$J"@#\
M7?AMXZ\0?"3_`(*/_M?:-:ZI_;&J:EX%N_B#;:-=:3/%<)X+O/$4&IKKVGR:
M9*=#OX-!BT[5-!DTXZ%>>*[U-.-W-J=Q>3R05Z#KOQ(^+W[6'P-_:&TJ;Q/H
M-OX1^.=E\2]<_8XTRU\$^+O`M]8^$?@EX[?1O[1UWQ/JNHV2ZHOQ$L-!M?B+
MIC:L_P`/?$OAK3=8_L"VL'ME+Q=I^W!X"M_@E^T'\&OVZ+"WCE7PZ-/^&7Q/
MNI+R6S%QX*GUN>\T0SFV5K27^P[K4;RWMK=M-%S.DBBYU1VB8R>3^+_$WPV^
M$GQ*M?VG/B]^T'^T5^T)\3?`GCYY?@;X:\)_#&XT?PQH7AKXQP:;:#X*>!/"
M/A632/"7Q!\0^(O#7B#0-*U;Q=XFO/%6N:;?V.KZQ<26UWIVIRP`'RS\4/C/
M#HOQ"\"_&/0[#Q3HO@'XEZ1X;^,_Q`\1^$O&_A32H=8\0>&]-O/AM\8_AGI?
M@_Q9HTNO>!M0\2R>"O"MI/K'PZU:.^DTW4]?GN[?Q`-5>>O-OVG/@_\`$?XT
M_$6R^(/@#Q3I_ACX#?M1?`*ZUZQ\33^(_'%AI'P\_:'U;Q3X?UG64M=8\,/<
M:A)#;VMKX<U[1!%HVEV&EZ''?VT\UU`=2N;+])_C9H5OX(\;7'A[7M=M/#WP
MG^)?B/2O$W[-_CJVGMM;T;X:?M&BRU6R\4>"/&,>DVOB+3!X0U.WL=2U^2]U
MVVN;%[W1]8TJ"X\0ZW:(+[X_\#M\4-&\7ZY\`OB7#XV\+:9;C2?!GAOQ!XIM
M/ACHM_\`#GQS!HGB36I;B3PSX?ENY/&GPZ^+ERWB7PB?%_A*S%C%X,\4:S->
M_P!D+IMDD(!\W_#G_@F#\7?#VL^`_!?B+]H7XDZOXI\*^)M;TKPUI6K?'+6]
M2GU+Q3X9\)PQVNI^)[C5O`MSX>\4V>@0PV?B'1YM5M=,BCV?\(ZZWMVIU]OO
M[P3^P5\</`_@G2O"1\:>&/'WBRTU#2[_`$N74-=@T^]<^&KC5;^6[TW[#JEE
M?I8:J(IK9=`T_4;2UT&_EE\1VMRZSS:2/SUTS]LC]J7X'?MS_LY_LLZQ\'O#
M?@?X?0Z9\9].\'Z^?&:^(+#X[>*=5\.6%U%H'BS5XK'Q#81:U\,O%%TT%F%U
MFQLO%/A54U7P]/<!!I-?H_J'[6?CKX?_`!;TN\^+OA-?B)XFO;^UU?X%>$?A
M]X=FM-0\4^*-9BU7X8:U\.#'<:=#<VEM93I_PD5WXNU*QAT?2K"T;5-5M]/T
MR^MM58`Q_`>EZWH_QBU;X87KZ%=:7J_AZ3QU\?/BKXF;3M9L(](T2XTQO'?@
MCQ?I5F8;#P1:SZ3!X>TGPO)#+,F@1^#=7N3!JPG>"WYC57\(?$G]OOX=#PS?
M7FI26W@'Q-J.EZ!H,VFZIJ?CK0]5O=+@TWQ797OBW6HO`OAKPU%X7\%1W_B7
M1X]%CU/Q;J%OHWB'1KR`O;Z=+VOC;Q=KVFP:QX&\0ZKX.\;_`!T^)VL>%I?B
M;K>H)X>\/>&8-(\8R:MK`^"]EJMO/H>EZKHOA*PDCT._O]4%W=V>B6VEW5Y)
MJ,WC-CI'1>%?@T/"6A6?P<\"^$?AC\)_VFOCK!?:]XY^(WA#S/BE%X*\*V&B
MV.J>.]1DN-2$7AO0X;HKX<T?PMX<_M[PI9Q1:OJ&H^#[Z]TZRABN0#UR+]J?
MX2?`'PQXI_:8^('B*R\/?#+XW_%74-"\+ZA>^&O%_F+X1\'Z;JEEJHDFTF#5
M)AJ6LZEHMU'I%QXBTSPE]DU(_P!AR0`K]I.9^V7\5=(^/GP2^"%KX)32]2L/
MB1^TY\,[7PY>VNM1WMAJ6B:/IB^)[O4)##&@BN_M-V-*EM;S>(9X6N9B68VB
MU/V@-3_:"\,:_P"!]1^`NFVFK?L^>%=".A:5\4O`WB.3XL>&;./5=.BT74M%
M^+OP"BMSJ'Q3TW4==,.H^'?%/@?7[V\\%7<%]?\`B%=2;49S;=;X4\(7WBW]
MJGP7X0T*?PNW@#X)>"+_`,2^/-5\&Z?:Z1X?UCXX7FN22^*=5'@B\T^Z?1FO
M=3DO4B:U\0:BMM&RK$)40`@'Z;^#=$70O"?AO1I(1'+I>BZ;8SH6BD*SVUK%
M%."\"1P.1,KY:&-(FZQHJ$`%=)"08U((8$$AE(96!)Y#*%4@]00J@CD`#BB@
M#S3XG?#/PO\`%[P)XI^'GC/2K76?#WBC3);*\LKE/E5]C&SN[9BQ\B\L[@I<
M)<#EY$`(120?QNT"T^)?PYFF^$4_@G4?BA\>/V-I/$NM?L?^&_'GB>?PIX4^
M/4>O65PDOB'6I;.VU..&^^&OA37[S2?!DT,>H76GV\^M3:A)?W>K0MI?[HL=
MZ*K$Y5LJRDJ0H/"\9Z#C.??':ODO]J[]GFY^/'A!9_!.NP^#/B_X3%SJ?@#Q
MS:I,=6TG44>,RV!9+FT,NGZE!`+&]@:X2-TD:0_+E&`/SIT+Q)XE^"GQ/TW]
MD?XB>,;W]L?7/'NBZ_\`&G]IK1[^PT'PW#\*Y[V=]3\':3\%M.T"TC;5-<%Y
M;:)H/A_X1MJEA>/X6T<^/K77;"^UC4[._P#:]5^!_CKX:>(-!L/'>C:S^T%\
M+-(T[68OAM\9;/P[HY_:`^"5GJ&GW,FF>%8,:;:KK&@:?:+#:#7O[<22]EU/
M6-!;PC;I,D[>E?`;XD:"?&]QI/QQ\.6_PG_:%GM[76?%^DR:5H)\(>-M<LUM
M_"/ASX@Z'KLFEWNIKK6I^&],B@MA%J=FMK97\R/I:2EHQXHUW^T;\)/$7C;Q
M[K^NZ[J?C_7_`(__`!3\<>(;K6!<ZA\*OA=^QAX!\.>(M:TR:T\/1ZY]CLX]
M0ET/2K'0+Z-9O$<NK^();R>Q=K>5+D`\>_:-^#/[.O[2_P`-HO#'A3XU?#>X
M\;^%+#3FMM3N]7TWP1J7BG7_``OJNI)X!C\<65K;:5?^'/$/@I['59?AKJVA
MR:>VM:[Y>C^(-#@MHTBC3]G#4O%7A+X=:1\6?VH/BE\-_B)\5KZRL]+\"+XA
M\8V6@V?P]\.RZ=;Z9XDEU35H-+U"^TQ/%>PZW,D4^O6_B'6)YO/GBT"6UT:T
M]P^&/Q@UOQ9^PK;?M<_M`?`WX6>,=6G^$7AKXPIX)M_`6F>'=8<2Z@-7M(;*
M/7+/QG:V>E6&F7.FZGI^JM_:DINEO;_[%"+\0P<=J?[36@^%OC1X3^"O@W]D
MWP!H=ZGCKP3X#\7>-]!\#:5KNG:9HGQ0^$UW\2?`'B/PMI'A[0+:Y>"UUS3+
M[P%XHTC4H[&+0KB&#5=.U+4K6:.R`!8^'WP>\/>+OB;XZ\9?#?PR^O>*]>1?
M.^/_`(K\#Z;X<^'7@.W$%A<0ZE\,-/M[Z^M_'7B.UT9]+OH9;\6=MXKT>PLH
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MAT'PSJNIW^C3R:CJ,]]J&C!89[*9XO-0`[7PY\,OV8OV+]6\5_&/X6^"_"_A
M+Q!\8)8KKX*Z3\/+GQ!:3_$.RUCP[97.O6>J?#ZT?1['4[7P;XGOY[RRO]8^
MU:FEELFN(8[E#(WZ%?LQ?"G4_AUX!MKKQIJ,VM_$7QO*WB+QCK]S-%>7MYJF
MI1IJ&HI!J,=O:R/ISZC-<36R2P*QAD42*6.5\'^`?[.?Q(\0?$*?X_?M.7VF
M7OC4W>_X=?#[1[DWGA3X76L%C'8*_A.VGL;.6PN;^VB#:L)D)N[C,D\:,2&_
M0E22H8AA(5`R^,H"/F0(#A/3`8A>@R.H!<@W&)-QW-CYFX&YLG)PH`Y//``]
M`!12P@"-0.`,@#.<#)QSW^M%`%,'(!]1F@\@9ZJ<JP"@J.XR%R0>G)Z=<GFB
MB@#SKXA_"CP'\5-,.D>.=!M]:LQ)%+"Q/V.]M)8"[0S6FI6(M]1@FB=Q(C"Z
M:,2*'$0).?@&\_9O_:_^!]QJ+?`KXNZ-\5_`*Z-=VFG?!_XFZ6D&HK)+"T=M
M-'XRU.YUJUU&6!);FU9=96*UNK*=89K:.>,W3_J'534?^0==?[C?R%`'X_\`
MB/XQ_M8R?#?QC\*/C'_P3S?5/A[?^'[?PI:>%?`OQ5\(KHTNA74<MO/IUM+H
MRW5Q86FFVSVMO;01PF%8K%%CMK='$<7&PZG\9]>L[P?#7_@FU-YTGBSPEX\U
M6Y\<?&>&&\U_7/A[81^$/#=Q9ZO>ZF]SIATC0[2Q@TBW2UET>ULH)[63P_*;
MQI(/VXT/_D$V'_7M%_Z`M7A_JT_ZX-_Z"E`'Y-Z1\$/VT_C)IMYH_P`3=7\.
M?LW^$K6QL-(M=&^'<>CZEJE_%HMUJ,D!OO$?A>[TGQ#)H&IS7\FIW_A1-7;3
M7UF6:]MK^.*7RA];?`/]D#X)_L]6-Q-X'\-K-XEU>"`Z[XKUNZU+7-1U.Z0)
M))<0Q>(+W5%TR*XG#7$L%IY4S22,7N"V:^D]+_UI_P"NC_UK4?[[?[S?S-`"
M;F`(W%^,*9-KL@/!`8*C$D<;F+-W))IH`4!5&%4`*"<D`#`!)Y.!W/6EHH`N
51?ZM?Q_]"-%$7^K7\?\`T(T4`?_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A10
<SEQUENCE>3
<FILENAME>v304809_exa10.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 50%; vertical-align: baseline; text-autospace: none; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: left; vertical-align: middle">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>EFiled: Mar 2 2012 8:22PM EST</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Transaction ID 42861209 Case</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>No. 7300-</B></P></TD>
    <TD STYLE="width: 10%; vertical-align: top; text-autospace: none; font-size: 10pt; text-align: right"><IMG SRC="seal.jpg" ALT=""></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 48%; vertical-align: top; border-top: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">STOURBRIDGE INVESTMENTS LLC,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">individually and on behalf of all others</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">similarly situated,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Plaintiff,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">vs.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">EDWARD H. BERSOFF, KEVIN S. FLANNERY, JOHN H. SCHULTE, EDWARD J.
        SMITH, ANITA K. JONES, JOEL R. JACKS, JAMES R. SWARTWOUT, ATS CORPORATION, SALIENT FEDERAL SOLUTIONS, INC. AND ATLAS MERGER SUBSIDIARY,
        INC.,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Defendants.</P></TD>
    <TD STYLE="width: 4%; vertical-align: baseline; text-autospace: none; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 48%; vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;<BR>
<BR>
</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">C.A. No.</P>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>VERIFIED CLASS ACTION COMPLAINT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
is a stockholder class action brought on behalf of the public stockholders of ATS Corporation (&ldquo;ATS&rdquo; or the &ldquo;Company&rdquo;)
against the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) for breaches of fiduciary duty arising out of Defendants&rsquo;
decision to sell the Company to Salient Federal Solutions, Inc., and its wholly-owned subsidiary Atlas Merger Subsidiary, Inc.
(collectively &ldquo;Salient&rdquo;), at an inadequate and for an unfair price following a grossly unfair process pursuant to an
Agreement and Plan of Merger between ATS and Salient dated as of February 21, 2012 (the &ldquo;Merger Agreement&rdquo;). Under
the Merger Agreement, the acquisition will take place in two stages: first an all-cash tender offer of $3.20 per ATS share (with
guarantees to acquire up to 90% of the outstanding shares) followed by a short-form merger (the &ldquo;Proposed Merger&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board&rsquo;s unanimous authorization to approve the Proposed Merger breached the fiduciary duties owed to ATS stockholders to
take all necessary steps to ensure that the stockholders would receive the maximum value realizable for their shares in any transaction
effecting the change of corporate control. In the context of this action, the Board failed to take all reasonable steps to assure
the maximization of stockholder value, including the implementation of a bidding mechanism to foster a fair auction of the Company
to the highest bidder or the exploration of strategic alternatives that would return greater or equivalent short-term value to
Plaintiffs and the Class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Tender Offer commenced on February 28, 2012 and is set to expire on March 26, 2012, unless extended in accordance with the terms
of the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
February 29, 2012, ATS publicly filed a Schedule 14D-9 (the &ldquo;14D-9&rdquo;) in connection with the proposed sale. As alleged
in more detail herein, the 14D-9 omits material information relating to the valuation of assets that stockholders would consider
in their determination of whether to accept the terms of the merger consideration or seek appraisal. For instance, the Company
has outstanding several government contract proposals, yet fails to disclose the relative probability of being awarded the contracts
and/or the potential effect on the Company&rsquo;s future revenues in the event it is awarded the respective contracts. Certain
of these contracts were identified by Salient during due diligence on February 3, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
May 2011, Salient first offered to acquire the Company at a significantly higher price than the agreed-to deal pursuant to the
Merger Agreement. Salient offered a price equivalent to an enterprise value range of between $100 million to $120 million. Also,
during the course of the sales process, two additional parties (identified in the 14D-9 as &ldquo;Party A&rdquo; and &ldquo;Party
C&rdquo;) offered to pay more than the $3.20 per share offered by Salient. Yet, the Company failed to explore one such offer of
$3.35 per share that remained open as it entered into the Proposed Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
Sagent Advisors Inc. (&ldquo;Sagent&rdquo;), the Company&rsquo;s financial advisor, had a prior relationship with Salient. There
is no indication, however, such relationship was disclosed to the Board at the time it first engaged Sagent in January 2011. Sagent
was involved in the sales process and persuaded the Board to discontinue discussions with, <I>inter alia</I>, Party C since Party
C had not completed its due diligence of ATS&mdash;even though Party C&rsquo;s offer at the time was $3.35 per ATS share, an offer
higher than Salient&rsquo;s. This prevented Party C from continuing with its higher offer of $3.35 per share or even potentially
increasing such offer. This is evidenced in the 14D-9 as representatives of Sagent reported that Party C had a substantial amount
of diligence still to be conducted and was not willing to increase its proposed $3.35 per share offering price. Removing Party
C from bidding for the Company permitted Salient to acquire the Company at the lower price of $3.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
Sagent&rsquo;s financial analysis is skewed towards presenting a <I>lower </I>value for ATS. For example, in its discounted cash
flow analysis, Sagent inexplicably selects a discount rate of 15Y2-16Y2 percent, even though the industry average is approximately
10% and ATS has neither fixed costs nor debt. Also, Sagent inexplicably selects a P/E ratio based on &ldquo;selected companies
multiples&rdquo; of 6.5x to 15.7x, when the lower multiple should be no less than 9.0x based on the selected comparable; upon closer
inspection, the 6.5x figure can only obtained by failing to exclude a single outlier comparable at the <I>low </I>end, even though
Sagent excludes an outlier comparable at the <I>high </I>end.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, Sagent&rsquo;s compensation for its &ldquo;fairness opinion&rdquo; is higher than usual since it amounts to approximately
1.5 percent of the current market valuation of the entire Company. And Sagent will receive the vast bulk of its compensation only
if the deal goes through: it obtained a $50,000 retainer fee and a $300,000 &ldquo;opinion fee,&rdquo; but will receive a &ldquo;transaction
fee&rdquo; of $750,000 only upon consummation of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Merger Agreement contemplates, among other things, a tender offer by Salient for all ATS shares at $3.20 per share conditioned
on obtaining 75% of the outstanding shares (the &ldquo;Tender Offer&rdquo;), a so-called &ldquo;Top-Up Option&rdquo; giving Salient
the right to buy additional new ATS shares at $3.20 to give Salient 90% ownership, enough to ensure a short-form merger at $3.20
per share. The Tender Offer commenced on February 28, 2012, and is set to expire on March 26, 2012. The closing is expected to
occur late in the first quarter or early in the second quarter of 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
ATS Board of Directors has unanimously recommended that ATS stockholders tender their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently
with the execution of the Merger Agreement and as a condition to Salient&rsquo;s willingness to enter into the Merger Agreement,
Salient entered into stockholder and undertaking agreements, dated as of February 21, 2012 (the &ldquo;Stockholder Agreements&rdquo;),
with certain directors of the Company and certain stockholders of the Company pursuant to which each of the stockholders agreed,
among other things, to tender shares aggregating 40% of the outstanding common stock pursuant to the Tender Offer and, if necessary,
vote such shares in favor of the adoption of the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consideration to be paid to the class members is unfair and grossly inadequate because, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
intrinsic value of the stock of ATS is materially in excess of $3.20 per share, giving due consideration to the possibilities of
growth and profitability of ATS in light of its business, earnings and earnings power, present and future;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
$3.20 per share price offers an inadequate premium to the public stockholders of ATS; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
$3.20 per share price is not the result of arm&rsquo;s-length negotiations but was fixed arbitrarily by certain insiders and Salient
to &ldquo;cap&rdquo; the market price of ATS stock, as part of a plan for Salient to obtain complete ownership of ATS assets and
business at the lowest possible price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
recent historical averages for ATS&rsquo;s stock price demonstrate that the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">consideration being offered by Salient is unfair
and inadequate. The $3.20 per share represents an inadequate premium to the trading price of the Company&rsquo;s common stock (which
as recently as June 24, 2011 closed at $4.75 per share).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendants
have exacerbated their breaches of fiduciary duty by agreeing to lock up the Proposed Merger with deal protection devices that
preclude other bidders from making a successful competing offer for the Company. Specifically, Defendants agreed to: (i) a no-solicitation
provision that prevents other buyers from having access to the Company&rsquo;s confidential information which information is necessary
to formulate a bid, except under extremely limited circumstances; (ii) a matching rights provision that allows Salient five business
days to match any competing proposal in the event one is made; and (iii) a provision that requires the Company to pay Salient a
termination fee of $1,500,000 (in addition to expenses of up to $1.0 million). These provisions limit the Board of Director&rsquo;s
ability to act with respect to investigating and pursuing superior proposals and alternatives including a sale of all or part of
ATS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Proposed Merger serves no legitimate business purpose for ATS but, rather, is an attempt by Defendants to enable Salient to benefit
unfairly from the transaction at the expense of ATS&rsquo;s public shareholders. The proposed cash-out transaction will forever
divest ATS public shareholders of their ownership interest in the Company for grossly inadequate consideration. As such, the Proposed
Merger will deny Plaintiff and the other members of the class their right to share proportionately in the future success of ATS
and its valuable assets, while permitting certain ATS insiders and Salient to reap huge financial benefits from the transaction.
Accordingly, judicial scrutiny of the Proposed Merger is necessary to ensure that the best interest of all ATS shareholders, and
not the interests of the Defendants, was the basis for the ATS Board decision to enter into the Proposed Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
entering into the Merger Agreement, each of the Defendants violated and continues to violate applicable law by directly breaching
and/or aiding and abetting the Defendants&rsquo; breaches of their fiduciary duties of loyalty, due care, independence, good faith
and fair dealing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
alleged herein, the Proposed Merger is the product of a hopelessly flawed process that was designed to sell ATS to Salient on terms
detrimental to Plaintiff and the other public stockholders of ATS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>PARTIES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff
is and has been at all relevant times a shareholder of ATS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ATS
is a Delaware corporation, founded in 1978, with its principal place of business located 7925 Jones Branch Drive, McLean, Virginia
22102.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ATS,
through its wholly owned subsidiary, Advanced Technology Systems, Inc., provides software and systems development, systems integration,
information sharing and assurance, information technology (&ldquo;IT&rdquo;) infrastructure and outsourcing, and IT and business
consulting services primarily to government agencies in the United States. It designs, develops, and delivers custom software systems
and applications and integrates commercial off the shelf solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company also provides life cycle requirements and configuration management, service-oriented architecture and system modeling and
design, application development, legacy migration and modernization, database architecture and implementation, system and software
operations and maintenance, independent verification and validation, multi-platform deployment, and information security certification
and accreditation support solutions. Its information sharing systems connect organizations of government, as well as give secure
and immediate access to information and communications; and IT infrastructure and outsourcing cover a range of infrastructure management
services from small email or Web server administration contracts to outsourced managed services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the Company provides a range of risk management services that ensure the security of information, networks, and systems;
a range of IT and business consulting services for government agencies, financial services firms, and property and casualty insurance
companies; and IT and business staffing services for technical and functional disciplines in financial institutions with specific
focus on business/data analysts and database professionals. It serves federal civilian agencies, defense and homeland security,
and state/local government.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of November 9, 2011, ATS has 22,972,686 shares of common stock outstanding. The Company&rsquo;s stock trades under the symbol &ldquo;ATSC&rdquo;
on the AMEX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Edward H. Bersoff (&ldquo;Bersoff&rdquo;) is and has been at all relevant times the Chairman of the Board of ATS. Bersoff served
as the Company&rsquo;s Vice Chairman from April 2005 through January 2007 when he became the Company&rsquo;s Chairman, President,
and Chief Executive Officer. As of January 1, 2011, he serves as Chairman and is no longer a Company employee. On December 15,
2010, Bersoff entered into a chairman agreement (the &ldquo;Bersoff Agreement&rdquo;) with the Company effective January 1, 2011
pursuant to which he would serve as the Company&rsquo;s Non-Executive Chairman of the Board of Directors until the later of June
30, 2012 or the Company&rsquo;s 2012 annual stockholders&rsquo; meeting (or any earlier change in control of the Company). The
terms of the Bersoff Agreement provide for (i) monthly payments of $13,333.33, paid quarterly, (ii) eligibility to receive future
equity award grants comparable to other members of the Board, and (iii) health insurance consistent with that of Company executives
through the termination date. The Bersoff Agreement also provides for a post termination eighteen-month non-solicitation and non-competition
term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Kevin S. Flannery (&ldquo;Flannery&rdquo;) is and has been at all relevant times a director of ATS since 2009.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Peter M. Schulte (&ldquo;Schulte&rdquo;) is and has been at all relevant times a director of ATS since 2005.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Edward J. Smith (&ldquo;Smith&rdquo;) is and has been at all relevant times a director of ATS since 2006.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Anita K. Jones (&ldquo;Jones&rdquo;) is and has been at all relevant times a Director of ATS since 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Joel R. Jacks (&ldquo;Jacks&rdquo;) is and has been at all relevant times a director of ATS since 2005. Jacks served as the Company&rsquo;s
Chairman and Chief Executive Officer from April 2005 until January 2007.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
James R. Swartwout (&ldquo;Swartwout&rdquo;) is and has been at all relevant times a director of ATS since 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Defendants named in &para;&para; 20-26 are sometimes collectively referred to herein as the &ldquo;Individual Defendants.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Salient, incorporated in Delaware, together with its subsidiary, provides federal information technology and engineering solutions
in the United States. It offers a full range of services to government customers in the core domains of cyber security, defense,
enterprise transportation, homeland security, and intelligence that include information technology life cycle management, engineering,
global telecommunications, information assurance, physical security, software development, systems engineering, space solutions,
and transportation logistics. Salient was founded in 2009 and is based in Fairfax, Virginia with additional offices in Charlotte,
Colorado Springs, Orlando, San Diego, and Tampa. Its principal offices are 4000 Legato Road, Suite 1100, Fairfax, VA 22033.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendant
Atlas Merger Subsidiary, Inc. (&ldquo;Atlas&rdquo;), a Delaware corporation, was organized as a wholly-owned subsidiary of Salient
for the sole purpose of making a tender offer for the outstanding shares of common stock of ATS and completing the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendants
Salient and Atlas are collectively referred to herein as &ldquo;Salient&rdquo;, and are named herein as aiders and abettors to
the Individual Defendants&rsquo; breaches of fiduciary duty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>CLASS ALLEGATIONS </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff
brings this action individually and as a class action pursuant to the rules of this Court, on behalf of all stockholders of ATS,
except Defendants herein and any person, firm, trust, corporation, or other entity related to or affiliated with any of the Defendants,
who are threatened with injury arising from Defendants&rsquo; actions as is described more fully below (the &ldquo;Class&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
action is properly maintainable as a class action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">33.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Class is so numerous that joinder of all members is impracticable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are over 22 million shares of ATS common stock outstanding held by hundreds of shareholders geographically dispersed across the
country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">35.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are questions of law and fact which are common to the Class including, <I>inter alia</I>, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;whether
Defendants have breached and are continuing to breach their fiduciary duties of undivided loyalty, independence or due care with
respect to Plaintiff and the other members of the Class in connection with the Proposed Merger; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;whether
Plaintiff and the other members of the Class would suffer irreparable injury were the transaction complained of herein consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">36.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff&rsquo;s
claims are typical of the claims of the other members of the Class and Plaintiff does not have any interests adverse to the Class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">37.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff
is an adequate representative of the Class, has retained competent counsel experienced in litigation of this nature and will fairly
and adequately protect the interests of the Class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">38.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
prosecution of separate actions by individual members of the Class would create a risk of inconsistent or varying adjudications
with respect to individual members of the Class which would establish incompatible standards of conduct for the party opposing
the Class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">39.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendants
have acted on grounds generally applicable to the Class with respect to the matters complained of herein, thereby making appropriate
the relief sought herein with respect to the Class as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>SUBSTANTIVE ALLEGATIONS </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">40.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
February 21, 2012, the Company and Salient jointly announced that they had entered into a definitive agreement or the Proposed
Merger for Salient to acquire the outstanding shares of ATS for $3.20 per share in an all-cash tender offer. The press release
stated in pertinent part:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">ATS Corporation (NYSE AMEX: ATSC),
a leading information technology company that delivers innovative technology solutions to government and commercial organizations,
and Salient Federal Solutions, Inc. (Salient), a leading provider of information technology, engineering, and intelligence analytic
services to agencies in the intelligence, defense, homeland security, and cyber domains, today announced that they have entered
into a definitive merger agreement, pursuant to which Salient will acquire ATSC through a cash tender offer at $3.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">The transaction will be financed from
Salient&rsquo;s equity capital commitments and debt financing. The proposed transaction has been unanimously approved by the board
of directors of both companies. In addition, certain ATSC board members have signed a tender and voting agreement in support of
the offer, and certain principal stockholders of ATSC have signed similar agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">Over its 33 year history, ATSC has
built a solid reputation for its implementation of technical solutions with measurable results. Together the organizations offer
a full suite of capabilities that will provide end-to-end solutions for customers across Federal civilian, Department of Defense
and intelligence agencies, as well as commercial clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">41.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently
with the execution of the Merger Agreement and as a condition to Salient&rsquo;s willingness to enter into the Merger Agreement,
Salient entered into the Stockholder Agreements with defendants Jacks, Schulte, and Bersoff of the Company in addition to certain
stockholders of the Company pursuant to which each of the stockholders agreed, among other things, to tender shares aggregating
40 percent of the outstanding common stock pursuant to the Tender Offer and, if necessary, vote such shares in favor of the adoption
of the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">42.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Stockholder Agreements, the Company&rsquo;s directors have agreed to tender or cause to be tendered to Salient in the Tender
Offer all of their shares of ATS common stock. The shareholders in the Stockholder Agreements also have agreed to vote, among other
things, in favor of the approval of the Merger Agreement, to the extent any such shares have not been previously accepted for payment
pursuant to the Tender Offer, and have given Salient an irrevocable proxy to vote each such shareholder&rsquo;s shares of ATS common
stock to that effect. In addition, such shareholders have agreed to waive any dissenters&rsquo; rights they may have and have agreed
not to take certain actions that ATS is prohibited from taking under the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">43.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immediately
prior to the announcement of the Merger, the Company announced its financial results for the 2011 fourth quarter and year end results.
Specifically, the Company reported the following booking highlights and management comments in addition to increased revenues for
the fourth quarter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><B>New Booking Highlights and Management Comments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">2011 net new bookings totaled approximately
$132 million, representing a book to bill ratio of 1.4x for the full year. The most significant new awards received during the
year included:</P>

<P STYLE="font: 10pt Symbol; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a $45.7 million five-year award with the Department of Housing and
Urban Development (&ldquo;HUD&rdquo;) for the continuation of the Company&rsquo;s application systems support for HUD&rsquo;s Single
Family Computerized Homes Underwriting Management System (&ldquo;CHUMS&rdquo;) and FHA Connection;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Symbol; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a $33.7 million, five-year contract with HUD, representing the continuation
of the Company&rsquo;s application systems support for three distinct HUD Single Family Premium Collections and Refund systems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Symbol; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a new single award Indefinite Delivery, Indefinite Quantity (&ldquo;IDIQ&rdquo;)
contract with a $30 million ceiling over a multiple year term, initially exercised at $20.4 million, with the Pension Benefit Guaranty
Corporation (&ldquo;PBGC&rdquo;) for the continuation of the Company&rsquo;s software development, maintenance, and operational
services in managing the Benefit Management Applications suite of solutions; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Symbol; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a $4.8 million, three-year task order in support of the U.S. Army
Intelligence and Security Command (&ldquo;INSCOM&rdquo;) in its efforts to recruit highly qualified cyber security professionals.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">ATSC Co-Chief Executive Officer and
Chief Financial Officer Pamela Little commented, &ldquo;2011 was a challenging year for the Company&rsquo;s top line and, as result,
our financial performance did not meet our expectations. Our federal business decline was driven by the increasingly difficult
Federal budget environment that delayed awards on a number of new contracts we are pursuing and postponed development funding or
reduced the initial scope on several sizeable recompetes we won this year. Our business with Fannie Mae also declined by nearly
50% over 2010 revenue due to delayed project starts and a resulting decrease in staffing levels. We were, however, pleased to see
revenue in our fourth quarter increase over the third quarter as we began receiving increased funding for development work on the
recompetes earlier mentioned. We also continued to manage our business to deliver above industry average EBITDA margins and maintain
strong DSO performance over the year, and as a result paid down our debt by over 86%, leaving a balance of $2 million at December
31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">ATSC Co-Chief Executive Officer John
Hassoun further commented on the Company&rsquo;s operations, &ldquo;We continued to maintain our strong federal business recompete
track-record in 2011, securing a number of our key programs for another five years and bringing an end to a series of major recompetes
successfully defended over the last 18 months. To build on this solid, multi-year foundation of business, we are now fully focusing
our business development efforts on new pursuits and remain optimistic in new awards from a number of outstanding bids in our pipeline.
Regarding our other business areas, we believe our commercial and Fannie Mae businesses have stabilized as we enter 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">44.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
$3.20 per share price agreed to by the Board does not currently represent fair value for the Company in that it does not reflect
the long-term value and future financial prospects of ATS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>THE PRECLUSIVE DEAL PROTECTION DEVICES
</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">45.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to agreeing to a sale of the Company at an unfair price, the Individual Defendants agreed to onerous deal protection devices
in breach of their fiduciary duties to ATS shareholders, which prevent a superior offer from being made for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">46.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Specifically,
Defendants agreed to: (i) a no-solicitation provision that prevents other buyers from having access to the Company&rsquo;s confidential
information which information is necessary to formulate a bid, except under extremely limited circumstances; (ii) a matching rights
provision that allows Salient 5 business days to match any competing proposal in the event one is made; and (iii) a provision that
requires the Company to pay Salient a termination fee of $1,500,000 (plus expenses up to $1.0 million). These provisions substantially
limit the Board&rsquo;s ability to act with respect to investigating and pursuing superior proposals and alternatives including
a sale of all or part of ATS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">47.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
terms of the Merger Agreement considerably restrain the Company&rsquo;s ability to solicit or engage in negotiations with any third
party regarding an acquisition proposal to the Company. The circumstances under which ATS&rsquo;s Board may respond to an unsolicited
written bona fide proposal for an alternative acquisition that constitutes or would reasonably be expected to constitute a superior
proposal are restrictive and fail to provide an effective fiduciary out under the circumstances of the case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">48.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Thus,
even if the Board were to receive a bid that appeared to be better than Salient&rsquo;s offer, these provisions unreasonably constrain
the Board&rsquo;s exercise of fiduciary responsibility to take measures to secure the best available transaction. Consequently,
this provision prevents the Board from exercising their fiduciary duties of &ldquo;shopping&rdquo; the Company and precludes an
investigation into competing proposals unless, as a prerequisite, the majority of the Board first determines that the proposal
is superior.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">49.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Merger Agreement, ATS granted Salient an option to purchase the number of authorized and unissued Company shares equal to
an additional number of ATS shares such that immediately after the issuance of those additional shares, Salient would own at least
90% of the outstanding shares of the Company (the &ldquo;Top-Up Option&rdquo;), in order to allow Salient to effect a short-form
merger pursuant to 8 Del. C. 253. The Top-Up Option provision is conditioned on Salient obtaining at least 75% of ATS&rsquo;s public
shares. In other words, if Salient acquires 75% of the currently outstanding shares in the Tender Offer (it has already locked
up approximately 40% of the Company&rsquo;s outstanding shares), the Top-Up Option irrevocably grants Salient the right to purchase
enough new ATS shares from the Company to bring Salient&rsquo;s ownership above the necessary 90% threshold for a short form merger
under Delaware law. Such purchase price may be paid by Salient, at its election, entirely in cash by wire transfer of same-day
funds or by paying in cash by wire transfer of same-day funds an amount equal to not less than the aggregate par value of such
Top-Up Shares and by executing and delivering to the Company a promissory note having a principal amount equal to the balance of
such purchase price. Any such promissory note shall be full recourse against Salient, shall bear interest at the rate of three
percent (3%) per annum, shall mature on the first (1st) anniversary of the date of execution and delivery of such promissory note
and may be prepaid without premium or penalty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">50.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Top-Up Option also provides a contractual right to Salient to attain the status of a 90% stockholder so long as at least 75% of
the outstanding shares tender, and thereby avoid voting requirement of Section 251 and the fairness standard on controlling stockholders
in transactions with the minority. The Top-Up and other preclusive deal protection devices constitute unfair and illegal abdications
of directors&rsquo; authority and unfair and inequitable evasion of stockholder rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>THE INADEQUATE DISCLOSURES IN THE 14D-9
</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">51.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
14D-9 omits material information relating to the valuation of assets that stockholders would consider in their determination of
whether to accept the terms of the merger consideration or seek appraisal. For instance, The Company has outstanding several government
contract proposals and fails to disclose the relative probability of being awarded the contracts or potential affect on the Company&rsquo;s
future revenues in the event it is awarded the respective contracts. Certain of these contracts were identified by Salient during
due diligence on February 3, 2012. Stockholders were not provided the information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">52.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
in May 2011, Salient offered to acquire the Company at a significantly higher price than the agreed to deal pursuant to the Merger
Agreement. Salient offered an enterprise value range of $100 million to $120 million. Also, in late September 2011 &ndash; at a
time that there still appeared to have been an active sales process &ndash; two additional parties, &ldquo;Party A&rdquo; and &ldquo;Party
C,&rdquo; were offering to pay more than the agreed to price with Salient and the Company failed to explore the remaining open
offer of $3.35 per share as it entered into the Proposed Merger. The 14D-9 fails to disclose why the Company discontinued discussions
with Party C at a time when it was offering a higher price ($3.35 per share) than Salient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">53.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
November 17, 2011, during a meeting of the Board, the Board discussed the possibility of moving in the direction of a long-form
merger rather than the tender offer approach. The 14D-9 does not disclose the concerns or reasons, if any, for reviewing alternatives
to the tender offer approach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>The Company&rsquo;s Financial Advisor
Is Conflicted</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">54.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Over
a year ago, on January 20, 2011, the Company engaged Sagent to assist and advise the Company Board in its review of such strategic
alternatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify; text-indent: 0.45in">55.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sagent
has acted as financial advisor to the Company in connection with the transaction and has received, or will receive, the following
compensation for its services: (i) a retainer fee of $50,000 (to be credited against the transaction fee); (ii) an opinion fee
of $300,000, which was payable upon rendering its opinion; and (iii) a transaction fee of approximately $750,000, which is contingent
upon the consummation of the Merger. In addition, the Company has agreed to reimburse a portion of Sagent&rsquo;s expenses and
indemnify Sagent for certain liabilities that may arise out of its engagement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify; text-indent: 0.45in">56.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Significantly,
the 14D-9 now discloses that Sagent performed various investment banking and financial services for Salient in connection with
its June 2010 acquisition of SGIS for $85 million cash and a contingent performance payment of up to $25 million, but did not receive
any fees. The 14D-9 further disclosed that, in the future, Sagent may perform various investment banking and financial services
for the Company and Salient, and expects to receive fees for such services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">57.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sagent,
the Company&rsquo;s financial advisor, had a prior relationship with Salient. There is no indication such relationship was disclosed
to the Board at the time it engaged Sagent in January 2011. Sagent was involved in the sales process and persuaded the Board to
discontinue discussions with Party C, since Party C required additional due diligence. This prevented Party C from continuing with
its higher offer of $3.35 per share or even potentially increasing such offer. According to the 14D-9, representatives of Sagent
reported that Party C was unwilling to increase its proposed $3.35 per share offering price but Party C still had a substantial
amount of due diligence remaining. Removing Party C from bidding for the Company permitted Salient to acquire the Company at the
lower price of $3.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">58.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, Sagent&rsquo;s analysis is skewed towards a lower valuation of ATS in at least two material aspects. In the discounted
cash flow analysis reported in the 14D9, Sagent inexplicably selects a discount rate of 15Y2-16Y2 percent, even though the industry
average is approximately 10% and ATS has neither fixed costs nor debt. Also, Sagent inexplicably selects a P/E ratio based on &ldquo;selected
companies multiples&rdquo; of 6.5x to 15.7x, when the lower multiple should be no less than 9.0x based on the selected comparable.
Upon closer inspection, the 6.5x figure can only obtained by failing to exclude a single outlier comparable at the <I>low </I>end,
even though Sagent excludes an outlier comparable at the <I>high </I>end.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>DEFENDANTS&rsquo; FIDUCIARY DUTIES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">59.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
reason of the Individual Defendants&rsquo; positions with the Company as officers and/or directors, said individuals are in a fiduciary
relationship with Plaintiff and the other public shareholders of ATS and owe Plaintiff and the other members of the Class a duty
of good faith, fair dealing, loyalty and full and candid disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">60.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
virtue of their positions as directors and/or officers of ATS, the Individual Defendants, at all relevant times, had the power
to control and influence, and did control and influence and cause ATS to engage in the practices complained of herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">61.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the Individual Defendants is required to act in good faith, in the best interests of the Company&rsquo;s shareholders and with
due care, including reasonable inquiry, as would be expected of an ordinarily prudent person. In a situation where the directors
of a publicly-traded company undertake a transaction that may result in a change in corporate control, Delaware law imposes the
obligation on the directors to take all steps reasonably required to maximize the value that shareholders will receive rather than
use a change of control to benefit themselves, and to disclose all material information concerning the proposed change of control
to enable the shareholders to make an informed voting decision. To diligently comply with this duty, the directors of a corporation
may not take any action that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;adversely
affects the value provided to the corporation&rsquo;s shareholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;contractually
prohibits them from complying with or carrying out their fiduciary duties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;discourages
or inhibits alternative offers to purchase control of the corporation or its assets; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;otherwise
adversely affects their duty to search and secure the best value reasonably available under the circumstances for the corporation&rsquo;s
shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>FIRST CAUSE OF ACTION </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Claim for Breach of Fiduciary Duties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.55in">62.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff
repeats and realleges each allegation set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">63.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Individual Defendants have violated their fiduciary duties of care, good faith, loyalty and candor owed under applicable law to
the public shareholders of ATS and have placed the interests of insiders ahead of the interests of ATS&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">64.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
demonstrated by the allegations above, the Individual Defendants failed to exercise the care required, and breached their duties
of loyalty, good faith, care and candor owed to the shareholders of ATS because, among other reasons:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they
failed to properly value ATS;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they
failed to take steps to maximize the value of ATS to its public shareholders and they took steps to avoid competitive bidding,
and to give Salient an unfair advantage, by, among other things, failing to adequately solicit other potential acquirors or alternative
transactions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they
failed to properly value ATS and its various assets and operations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they
failed to provide shareholders with the material information necessary to make an informed decision as to whether or not to vote
in favor of the Proposed Merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they
erected unreasonable barriers to other third-party bidders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">65.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
the acts, transactions and courses of conduct alleged herein, the Individual Defendants, individually and as part of a common plan
and scheme and in breach of their fiduciary duties of loyalty, good faith and due care to Plaintiff and the other members of the
Class, have failed to adequately inform themselves about the true value of the Company and, by agreeing to the Proposed Merger
with Salient, will unfairly deprive Plaintiff and other members of the Class of the true value of their investment in ATS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">66.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ATS
shareholders will, if the Proposed Merger is consummated, be deprived of the opportunity for substantial gains which the Company
may realize.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">67.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
reason of the foregoing acts, practices and course of conduct, the Individual Defendants have failed to exercise care and diligence
in the exercise of their fiduciary obligations toward Plaintiff and the other ATS public stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">68.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result of the actions of Defendants, Plaintiff and the other members of the Class have been and will be damaged in that they
have not and will not receive their fair proportion of the value of ATS&rsquo;s assets and businesses and will be prevented from
obtaining appropriate consideration for their shares of ATS common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">69.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
enjoined by this Court, the Defendants will continue to breach their fiduciary duties owed to Plaintiff and the other members of
the Class, and may consummate the Proposed Merger which will exclude the Class from its fair proportionate share of ATS&rsquo;s
valuable assets and businesses, all to the irreparable harm of the Class, as aforesaid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-indent: -0.1in"><B>70.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Plaintiff
and the Class have no adequate remedy at law. Only through the exercise of this Court&rsquo;s equitable powers can Plaintiff and
the Class be fully protected from the immediate and irreparable injury which Defendants&rsquo; actions threaten to inflict.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-indent: -0.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B><U>SECOND
CAUSE OF ACTION </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Claim for Aiding and Abetting the<BR>
Individual Defendants&rsquo; Breaches of Fiduciary Duty</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">71.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff
incorporates by reference and realleges each and every allegation contained above, as though fully set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">72.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Salient
and Atlas have knowingly aided and abetted the Individual Defendants&rsquo; wrongdoing alleged herein. Salient and Atlas are also
active and necessary participants in the Individual Defendants&rsquo; plan to consummate the Proposed Merger on terms that are
unfair to ATS shareholders, as Salient seeks to pay as little as possible to ATS shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify; text-indent: -0.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify; text-indent: -0.1in">73.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff
has no adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>PRAYER FOR RELIEF </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in"><B>WHEREFORE</B>, Plaintiff
demands relief in their favor and in favor of the Class and against Defendants as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Declaring
that this action is properly maintainable as a Class action and certifying Plaintiff as a representative of the Class;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enjoining
Defendants, their agents, counsel, employees and all persons acting in concert with them from consummating the Proposed Merger,
unless and until the Company adopts and implements a procedure or process to obtain a merger agreement providing the best possible
terms for shareholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enjoining
Defendants from consummating the Merger Agreement and Proposed Merger unless and until they provide to ATS shareholders all material
information in connection with the proposed transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awarding
Plaintiff the costs and disbursements of this action, including reasonable attorneys&rsquo; and experts&rsquo; fees; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Granting
such other and further relief as this Court may deem just and proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: baseline">
    <TD STYLE="width: 50%; text-autospace: none">DATED: March 2, 2012</TD>
    <TD STYLE="width: 50%; text-autospace: none">Respectfully submitted,</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-weight: bold">SIANNI &amp; STRAITE LLP</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD STYLE="text-autospace: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none; font-style: italic">&nbsp;</TD>
    <TD STYLE="border-bottom: windowtext 1pt solid; text-autospace: none; text-align: center">/s/ <I>Ralph N. Sianni</I></TD></TR>
<TR>
    <TD STYLE="vertical-align: baseline; text-autospace: none">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ralph N. Sianni (Del. Bar No. 4151)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">David A. Straite (Del Bar No. 5428)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1201 N. Orange St., Suite 740</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Wilmington, DE 19801</P></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD STYLE="text-autospace: none">Tel.: (302) 573-3560</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD STYLE="text-autospace: none">Fax: (302) 358-2975</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none; font-style: italic">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-style: italic; text-decoration: underline">rsianni@siannistraite.com</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none; font-style: italic; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-style: italic; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="text-autospace: none; font-style: italic; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-style: italic; font-weight: bold">Counselfor Plaintiff</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">OF COUNSEL:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>HARWOOD FEFFER LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Robert Harwood</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">James G. Flynn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">488 Madison Avenue, 8th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(212) 935-7400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(212) 753-3630 (fax)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>LAW OFFICES OF JOSHUA M. LIFSHITZ</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Joshua M. Lifshitz</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">18 East 41st Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Suite 1105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tel: (212) 213-6222</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Fax: (212) 213-9405</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A11
<SEQUENCE>4
<FILENAME>v304809_exa11.htm
<DESCRIPTION>EXHIBIT 99.A11
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt/23.25pt Times New Roman, Times, Serif; margin: 2.05pt 0 0; text-align: center"><B>UNITED STATES DISTRICT COURT</B></P>

<P STYLE="font: 10pt/13.9pt Times New Roman, Times, Serif; margin: 1pt 0 20.6pt; text-align: center"><B>EASTERN DISTRICT OF VIRGINIA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4in; text-indent: -4in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: baseline">
    <TD STYLE="width: 60%; padding: 0; font-weight: bold">GIANCARLOS GUERRA, on behalf of himself</TD>
    <TD STYLE="width: 40%; padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">and all others similarly situated,</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold; text-indent: 0.24in">Plaintiff,</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>) Civil Action No.</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">vs.</TD>
    <TD STYLE="padding: 0"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>) JURY TRIAL DEMANDED</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">ATS CORPORATION, EDWARD H. BERSOFF,</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">KEVIN FLANNERY, JOEL JACKS, ANITA K.</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>) CLASS ACTION</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">JONES, PETER SCHULTE, EDWARD SMITH,</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">JAMES R. SWARTWOUT, SALIENT</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">FEDERAL SOLUTIONS, INC. and ATLAS</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">MERGER SUBSIDIARY, INC.,</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-weight: bold; text-indent: 0.12in">Defendants.</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold"><B>)</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4in; text-indent: -4in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4in; text-indent: -4in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 20pt 0 12pt; text-align: center"><B><U>CLASS ACTION COMPLAINT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Plaintiff Giancarlos Guerra (&ldquo;Plaintiff&rdquo;),
by his attorneys, alleges upon information and belief, except for those allegations that pertain to him, which are alleged upon
personal knowledge, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">1.<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9;</FONT>Plaintiff
brings this shareholder class action on behalf of himself and all other public shareholders of ATS Corporation (&ldquo;ATS&rdquo;
or the &ldquo;Company&rdquo;) against the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo; or the &ldquo;Individual
Defendants&rdquo;) seeking equitable relief for their violations of Rule 14(e) promulgated under the Securities Exchange Act of
1934 (&ldquo;Rule 14(e)&rdquo;) and breaches of fiduciary duty arising out of the attempt to sell the Company to Salient Federal
Solutions, Inc. and Atlas Merger Subsidiary, Inc. (the &ldquo;Merger Sub&rdquo;) (collectively &ldquo;Salient&rdquo;), by means
of an unfair process and for an unfair price (the &ldquo;Proposed Acquisition&rdquo;). The Proposed Acquisition is structured as
a first-step tender offer and second step short-form merger to cash out any ATS stockholders who do not tender (the &ldquo;Merger&rdquo;).</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">2.&#9;Under the terms of a definitive
merger agreement announced on February 21, 2012 (the &ldquo;Merger Agreement&rdquo;), Salient commenced a cash tender offer on
February 28, 2012 to acquire ATS&rsquo;s outstanding shares of common stock at $3.20 per share (the &ldquo;Tender Offer&rdquo;).
The Tender Offer is set to expire on March 26, 2012. The Proposed Acquisition has a total approximate value of $77 million and
is expected to occur late in the first quarter or early in the second quarter of 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">3.&#9;The Merger Agreement grants Salient
an irrevocable Top-Up Option to purchase a sufficient number of shares that, when added to the shares purchased in the Tender Offer,
will give Salient one share more than 90% of the Company&rsquo;s outstanding shares on a fully diluted basis. The Top-Up Option
could result in the issuance of millions of additional shares of ATS stock (the &ldquo;Top-Up Shares&rdquo;), and will enable Salient
to complete the Transaction via a short-form Merger without the vote of single public stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">4.&#9;On February 28, 2012, Salient issued
its Offer to Purchase (the &ldquo;Offer to Purchase&rdquo;) soliciting stockholder support for the Tender Offer. Also on February
28, 2012, ATS filed its Solicitation/Recommendation Statement with the SEC on Form SC 14D9 (the &ldquo;14D9&rdquo;) pursuant to
which ATS&rsquo;s Board recommends that ATS stockholders tender their shares in the Tender Offer and, if necessary, vote in favor
of the Merger. The 14D9 omits material information necessary for shareholders to make an informed decision whether to tender their
shares or to vote in favor of the Merger.</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">5.&#9;As alleged
herein, the Individual Defendants have breached their fiduciary duties of loyalty and due care by, <I>inter alia, </I>being bullied
into selling the Company by certain large shareholders; purposefully and intentionally neglecting the business while seeking a
buyer and, thus, agreeing to sell ATS for inadequate consideration without ensuring that Plaintiff and Class members (defined below)
would obtain adequate and fair consideration under the circumstances. Salient aided and abetted the Individual Defendants&rsquo;
breaches of fiduciary duty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 4.5pt; text-indent: 31.5pt">6.<FONT STYLE="font-size: 10pt"><B>&#9;</B></FONT>Plaintiff
seeks to enjoin the Proposed Acquisition or, alternatively, to recover damages in the event that the Proposed Acquisition is consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>JURISDICTION AND VENUE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">7.&#9;This Court has subject matter jurisdiction
under 28 U.S.C. &sect; 1331 (federal question jurisdiction), as this Complaint alleges violations of Rule 14(e). This Court has
jurisdiction over the state law claims pursuant to 28 U.S.C. &sect; 1367.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">8.&#9;Alternatively, this Court has subject
matter jurisdiction over this action pursuant to 28 U.S.C. &sect; 1332(a) (2) because complete diversity exists between Plaintiff
and each Defendant, and the amount in controversy exceeds $75,000, exclusive of interest and costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">9.&#9;Venue is proper because Defendants
reside, are found, have agents, an regularly transact business in this District as provided in 28 U.S.C. &sect; 1391(b) and (c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">10.&#9;This Court has personal jurisdiction
over the Defendants because they are located in, transacted business in, or had substantial contacts with this District.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">11.&#9;Plaintiff Giancarlos Guerra is,
and has been at all relevant times a shareholder of ATS. Plaintiff is an employee of ATS.</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">12.&#9;ATS Corporation, through its subsidiary,
Advanced Technology Systems, Inc., provides software and systems development, systems integration, information sharing and assurance,
information technology (IT) infrastructure and outsourcing, and IT and business consulting services primarily to government agencies
in the United States. ATS designs, develops, and delivers custom software systems and applications and integrates commercial off
the shelf solutions. The Company is incorporated in the state of Delaware and headquartered at 7925 Jones Branch Drive, McLean,
VA 22102. The Company&rsquo;s common stock is traded on AMEX under the symbol &ldquo;ATSC.&rdquo; As of February 29, 2012, the
Company had approximately 22.97 million shares of common stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">13.&#9;Defendant Edward H. Bersoff, (&ldquo;Bersoff&rdquo;)
is the Chairman of the Board of ATS Bersoff served as Chairman, President and CEO of ATS from 2007 through 2010. Bersoff, the beneficial
owner (as defined under Rule 13d-3 of the Exchange Act) of an aggregate of 225,000 shares of Company Common Stock (which does not
include (i) shares underlying any Company Employee Stock Options, (ii) 650,000 shares subject to planned gifts for estate planning
or other purposes and (iii) 75,000 shares that are otherwise not subject to the terms of this Agreement), as a condition to entering
into the Merger Agreement, has agreed to tender his shares and has also agreed not to initiate, solicit, knowingly facilitate or
knowingly encourage any inquiry or the making of any proposal that constitutes or could reasonably be expected to lead to a Company
Takeover Proposal (the &ldquo;Stockholder Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">14.&#9;Defendant Kevin S. Flannery, (&ldquo;Flannery
&ldquo;) has been a Director of the Company since June 1, 2009. Flannery is a member of the Compensation and Nominating and Corporate
Governance Committees. Upon consummation of the Proposed Acquisition, Flannery will receive $78,996.00 in cash based on equity
awards held as of February 28, 2012.</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">15.&#9;Defendant Joel Jacks, (&ldquo;Jacks&rdquo;)
has served as a Director of the Company since April 2005. Jacks is Chairman of the Compensation Committee and a member of the Audit
Committee. Jacks, the beneficial owner (as defined under Rule 13d-3 of the Exchange Act) of an aggregate of 1,035,564 shares of
Company Common Stock (which does not include (i) shares of Company Restricted Stock or (ii) shares underlying any Company Employee
Stock Options), as a condition to entering into the Merger Agreement, has agreed to tender his shares and has also agreed to the
Stockholder Agreement. Upon consummation of the Proposed Acquisition, Jacks will receive $44,084.00 in cash based on equity awards
held as of February 28, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">16.&#9;Defendant Anita K. Jones (&ldquo;Jones&rdquo;)
has been a Director of the Company since May 18, 2010. Jones is a member of the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">17.&#9;Defendant Peter Schulte, (&ldquo;Schulte&rdquo;)
has been a Director of the Company since April 2005. Schulte is the Chairman of the Nominating and Corporate Governance Committee
and a member of the Compensation Committee. Schulte, the beneficial owner (as defined under Rule 13d-3 of the Exchange Act) of
an aggregate of 963,284 shares of Company Common Stock (which does not include (i) shares of Company Restricted Stock or (ii) shares
underlying any Company Employee Stock Options), as a condition to entering into the Merger Agreement, has agreed to tender his
shares and has also agreed to the Stockholder Agreement. Upon consummation of the Proposed Acquisition, Schulte will receive $44,084.00
in cash based on equity awards held as of February 28, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">18.<FONT STYLE="font-size: 10pt">&#9;</FONT>Defendant
Edward J. Smith, (&ldquo;Smith&rdquo;) has been a Director of the Company since May 2006. Smith is Chairman of the Audit Committee
and a member of the Nominating and Corporate Governance Committee. Upon consummation of the Proposed Acquisition, Smith will receive
$65,130.00 in cash based on equity awards held as of February 28, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">19.<FONT STYLE="font-size: 10pt">&#9;</FONT>Defendant
James R. Swartwout, (&ldquo;Swartwout&rdquo;) has been a Director of the Company since May 18, 2010. Swartwout is a member of the
Audit and Nominating and Corporate Governance Committees.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">20.&#9;Individual Defendants Edward H.
Bersoff, Joel Jacks, Anita Jones, Kevin Flannery, Peter Schulte, Edward J. Smith and James R. Swartwout are, and at all times relevant
hereto have been, directors of ATS, and are referred to herein as &ldquo;Individual Defendants&rdquo; or &ldquo;Director Defendants.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">21.&#9;The Director Defendants, by reason
of their corporate directorships and/or executive positions, are fiduciaries to and for the Company&rsquo;s stockholders, which
fiduciary relationship required them to exercise their best judgment, and to act in a prudent manner and in the best interests
of the company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">22.&#9;Defendant Salient is a leading
provider of Federal IT and engineering solutions that enable government and industry to respond quickly to new or surge mission
requirements. Salient Federal Solutions is headquartered in Fairfax, Virginia, with offices in Colorado Springs, Orlando, San Diego,
and Tampa.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">23.&#9;Defendant Atlas Merger Subsidiary,
Inc. (the &ldquo;Merger Sub&rdquo;) is a Delaware corporation and a wholly-owned subsidiary of Salient formed for the purpose of
effecting the Proposed Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">24.&#9;Salient and Merger Sub are sometimes
referred to collectively herein as the &ldquo;Salient Defendants.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>SUBSTANTIVE ALLEGATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">25.&#9;On January
7, 2011, the Company issued a press release announcing a strategic evaluation and change of management leadership. The press release
states in relevant part:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">MCLEAN, VA &mdash; (PRNEWSWIRE)
&mdash; January 7, 2011. ATS Corporation (&ldquo;ATSC&rdquo; or the &ldquo;Company&rdquo;) (NYSE Amex: ATSC), a leading information
technology company that delivers innovative technology solutions to government and commercial organizations, today announced that
the Board of Directors has begun a process to evaluate strategic alternatives for the Company. Board Chairman Dr. Edward H. Bersoff
explained that &ldquo;The Board continues to believe that the current market value of the Company&rsquo;s shares does not reflect
its underlying value and prospects.&rdquo; There can be no assurance that the review of strategic alternatives will result in
the Company pursuing any particular transaction, or, if it pursues any such transaction, that it will be completed.&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">The Company also announced that
President and Chief Executive Officer Sidney E. Fuchs, who joined the Company during 2010, has decided to depart from the Company.
Dr. Bersoff commented, &ldquo;In light of the Board&rsquo;s decision to begin this process, Sid concluded that it was in his best
interests to pursue other opportunities.&rdquo;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">In terms of ongoing leadership,
Executive Vice President and Chief Financial Officer Pamela A. Little and Senior Vice President John Hassoun have become Co-Chief
Executive Officers, with Ms. Little having primary responsibility for financial and administrative aspects of the Company&rsquo;s
affairs and Mr. Hassoun having primary responsibility for operational matters, such as pursuit and execution of contracts.<FONT STYLE="letter-spacing: -0.25pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0in; text-indent: 0.5in; text-align: justify">26.&#9;On
February 21, 2012, more than a year after announcing the strategic evaluation, ATS announced that it would be acquired by Salient
in a transaction valued at $77 million. The press release states in relevant part:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">McLean and Fairfax, Virginia,
February 21, 2012 <U>ATS Corporation</U> (NYSE AMEX: ATSC), a leading information technology company that delivers innovative technology
solutions to government and commercial organizations, and Salient Federal Solutions, Inc. (&ldquo;Salient&rdquo;), a leading provider
of information technology, engineering, and intelligence analytic services to agencies in the intelligence, defense, homeland security,
and cyber domains, today announced that they have entered into a definitive merger agreement, pursuant to which Salient will acquire
ATSC through a cash tender offer at $3.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">The transaction will be financed
from Salient&rsquo;s equity capital commitments and debt financing. The proposed transaction has been unanimously approved by the
board of directors of both companies. In addition, certain ATSC board members have signed a tender and voting agreement in support
of the offer, and certain principal stockholders of ATSC have signed similar agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">Over its 33 year history, ATSC
has built a solid reputation for its implementation of technical solutions with measurable results. Together the organizations
offer a full suite of capabilities that will provide end-to-end solutions for customers across Federal civilian, Department of
Defense and intelligence agencies, as well as commercial clients.</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">&ldquo;ATSC&rsquo;s long-term
performance in delivering high-quality solutions and services within the federal marketplace is evident through the many long-standing
relationships it has with its customers,&rdquo; said Brad Antle, president and CEO of Salient. &ldquo;We look forward to the opportunity
to build on ATSC&rsquo;s offerings and relationships, where we can help them address the many immediate customer requirements for
delivery of rapid solutions.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify">&ldquo;We believe this transaction
will expand the opportunities for both our customers and employees as the combination of ATSC and Salient will allow us to extend
the range and depth of solutions we can offer as well as open new markets to pursue,&rdquo; commented ATSC Co-Chief Executive Officers,
Pamela Little and John Hassoun</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><B>Tender Offer and Closing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify">Under the terms of the definitive
merger agreement, Salient will commence a cash tender offer no later than February 28, 2012 to acquire ATSC&rsquo;s outstanding
shares of common stock at $3.20 per share. The closing of the tender offer, which is expected to occur late in the first quarter
or early in the second quarter of 2012, is subject to customary terms and conditions, including the tender of at least 75% of ATSC&rsquo;s
shares and regulatory clearance under the Hart-Scott-Rodino Antitrust Improvements Act. In the event the minimum tender condition
is not met, and in certain other circumstances, the parties have agreed to complete the transaction through a one-step merger after
receipt of stockholder approval. The definitive merger agreement also provides for customary termination fees payable by either
Salient or ATSC under certain circumstances, and a provision under which ATSC has agreed not to solicit any competing offers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">27.&#9;As set forth herein, after being
bullied into seeking a sale of the Company by certain large shareholders and purposefully and intentionally neglecting the business,
the Individual Defendants compounded their breaches of fiduciary duty by still failing to maximize shareholder value and obtain
an adequate price for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in; text-align: justify">28.&#9;The analyses performed by the Company&rsquo;s
financial advisor, Sagent Advisors Inc. (&ldquo;Sagent&rdquo;), demonstrate that the offer is woefully inadequate. For example,
a review of Sagent&rsquo;s Discounted Cash Flow Analysis and Precedent Transactions Analysis in the 14D9 establishes an implied
valuation range of $3.21-$4.21 per ATS share, all of which is above the deal price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">29.&#9;Further to this point, since February
2, 2012, when ATS stock reached an intra<FONT STYLE="font-size: 10pt">-</FONT>day trading high of $3.35 per share, ATS stock trade above the $3.20 offer price each and every day prior to the announcement
of the Proposed Acquisition. In fact, the closing price for ATS stock was actually $0.05 per share higher than the offer price
on February 17, 2012 &mdash; the last business day prior to the announcement of the Proposed Acquisition, and the 20-day average
closing price of ATS stock prior to the deal&rsquo;s announcement was less than $0.01 below the offer price. Additionally, ATS
shares reached a 52 week high of $4.75 per share as recently as June 2011.</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">30.&#9;A recent review of ATS on <I>Seeking
Alpha </I>indicates that the Company is undervalued as it is trading at a significant discount to its Graham Number of $4.16 per
share<FONT STYLE="font-size: 8pt"><SUP>1</SUP></FONT>, 30% greater than the offer price and entirely in line with Sagent&rsquo;s
DCF and Precedent Transaction valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">31.&#9;The upward trajectory of ATS&rsquo;s
stock price is likely to continue. As ATS Co-Chief Executive Officer John Hassoun (&ldquo;Hassoun&rdquo;) stated in the Company&rsquo;s
press release for the fourth quarter of 2011:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in">&ldquo;We continue to maintain our strong federal
business recompete track-record in 2011, securing a number of our key programs for another five years and bringing an end to a
series of major recompetes successfully defended over the last 18 months. To build on this solid, multi-year foundation of business,
we are now fully focusing our business development efforts on new pursuits and remain optimistic in new awards from a number of
outstanding bids in our pipeline. Regarding our other business areas, we believe our commercial and Fannie Mae businesses have
stabilized as we enter 2012.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">32.&#9;On February 8, 2012, ATS announced
it was awarded a five-year General Services Administration (&ldquo;GSA&rdquo;) Mission Oriented Business Integrated Services (&ldquo;MOBIS&rdquo;)
schedule contract. The MOBIS program offers a broad range of management and consulting services to help Federal agencies optimize
their performance toward achieving mission goals. Said Little, &ldquo;ATSC is pleased to have been awarded this schedule contract
because of the opportunities it provides to apply our deep program management support expertise in support of Federal agencies&rsquo;
efforts to better align their projects with mission goals while enhancing their responsiveness to changing requirements and reducing
risks and costs.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;<FONT STYLE="font-size: 8pt"><SUP>1</SUP></FONT> The Graham
Number is a measure of a stock&rsquo;s maximum fair value and is equal to the Square Root of 22.5 x TTM EPS x MRQ Book Value per
Share. The Graham Number is the maximum price that a value investor should pay for a given stock. A stock whose share price is
below the Graham Number is considered to be undervalued or of good value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">33.&#9;Significantly, on February 20,
2012, the Company determined that it will pay a one-time cash bonus of $123,333 to Little and $95,000 to Hassoun conditioned upon
and paid only upon consummation of the contemplated transaction. Upon consummation of the Proposed Acquisition, Little will also
receive and additional $330,335.00 in cash based on equity awards held as of February 28, 2012, as well as $555,000 in <I>Change
in Control Provision </I>payments, and Hassoun will receive an additional $24,000.00 in cash based on equity awards held as of
February 28, 2012, as well as $285,000 in <I>Change in Control Provision </I>payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">34.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;</FONT>According
to Little, as of November 14, 2011, &ldquo;the Company continues to believe it is well-positioned to win new contracts already
submitted and continues to submit proposals for additional new contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">35.&#9;Moreover, individual Defendants
Bersoff, Schulte and Jacks, as a condition to<BR>
their willingness to enter in the Merger Agreement, have executed Stockholder Agreements with Salient pursuant to which they have
agreed to accept the Offer with respect to all their shares, a combined 2,223,848 shares of Company common stock, and to tender,
or cause to be tendered the shares, free and clear of any liens, pursuant to the Offer. These Individual Defendants have also agreed
not initiate, solicit, knowingly facilitate or knowingly encourage any inquiry or the making of any proposal that constitutes or
could reasonably be expected to lead to a Company Takeover Proposal.</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">36.<FONT STYLE="font-size: 10pt">&#9;</FONT>As
a condition to the consummation of the Proposed Acquisition, at least 75% of the outstanding shares of common stock on a fully
diluted basis shall have been validly tendered and not withdrawn in accordance with the terms of the Offer. Significantly, via
the Stockholder Agreements executed by Defendants Bersoff, Schulte and Jacks together with the Lampe Conway Undertaking Agreement
(2,206,517 shares), the Revelation Undertaking Agreement (2,323,370 shares), the Carl Marks Undertaking Agreement (1,538,870 shares)
and the Minerva Undertaking Agreement (947,630 shares)(collectively referred to as &ldquo;Support Agreements&rdquo;), approximately
40% of ATS common stock has already agreed to accept the Offer and to tender, or cause to be tendered, all such shares, free and
clear of any liens, pursuant to the Offer and to vote such shares in favor of the adoption of the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.05in; text-indent: 0.5in">37.<FONT STYLE="font-size: 10pt">&#9;</FONT>In
connection with the consummation of the Proposed Acquisition, ATS&rsquo; Board of Directors and executive officers will enjoy benefits
not shared equally with Plaintiff and the class including, (i) the accelerated vesting of options to purchase shares of Company
Common Stock (&ldquo;Company Stock Options&rdquo;) immediately prior to the consummation of the Offer, and the settlement of such
options in exchange for cash; (ii) the accelerated vesting of Company restricted stock awards (&ldquo;Company Restricted Stock&rdquo;)
subject to vesting or other forfeiture conditions or repurchase by the Company immediately prior to the consummation of the offer,
and the cancellation of such awards in exchange for cash; and (iii) in the case of executive officers, the receipt of certain payments
and benefits under the executive officers&rsquo; employment agreements following a change in control of the Company and the occurrence
of certain other events.</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">38.&#9;In addition, the press release
expressly acknowledged that the Proposed Acquisition is calculated to benefit Salient. Specifically, the press release provides,
in pertinent part, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">&ldquo;ATSC&rsquo;s long-term
performance in delivering high-quality solutions and services within the federal marketplace is evident through the many long-standing
relationships it has with its customers,&rdquo; said Brad Antle, president and CEO of Salient. &ldquo;We look forward to the opportunity
to build on ATSC&rsquo;s offerings and relationships, where we can help them address the many immediate customer requirements for
delivery of rapid solutions.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">39.&#9;Clearly, based on the above, the
Proposed Acquisition will allow Salient to purchase ATS at an unfairly low price while availing itself of ATS&rsquo;s significant
value and upside or long-term potential.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>PRECLUSIVE DEAL PROTECTION MECHANISMS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">40.&#9;The Merger Agreement contains
certain provisions that unfairly favor Salient by making an alternative transaction either prohibitively expensive or otherwise
impossible. For example, the Merger Agreement contains a termination payment provision that requires ATS to pay $1,500,000.00,
plus reasonable out-of-pocket expenses (not to exceed $1,000,000.00), to Salient if the Merger Agreement is terminated under certain
circumstances. For instance, under one scenario, ATS must pay this fee even if it consummates any Company Takeover Proposal (as
defined in the Merger Agreement) within 12 months following the termination of the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">41.&#9;The termination fee payable under
this provision will make the Company that much more expensive to acquire for potential purchasers, while resulting in a corresponding
decline in the amount of consideration payable to ATS shareholders.</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">42.&#9;The Merger Agreement also contains
a &ldquo;no solicitation&rdquo; provision that restricts ATS from considering alternative acquisition proposals by, <I>inter alia,
</I>constraining ATS&rsquo;s ability to solicit or communicate with potential acquirers or consider their proposals. Specifically,
the provision prohibits the Company from soliciting any alternative proposal after a brief defined time period, but permits the
Board to consider a <I>&ldquo;bona fide written Company Takeover Proposal&rdquo; if </I>it constitutes or is reasonably calculated
to lead to a <I>&ldquo;Superior Company Proposal&rdquo; </I>as defined in the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">43.&#9;Moreover, the Agreement further
reduces the possibility of a topping offer from an unsolicited purchaser. Here, Defendants agreed to provide Salient information
in order to match any other offer, thus providing Salient access to the unsolicited bidder&rsquo;s financial information and giving
Salient the ability to top the superior offer. Thus, a rival bidder is not likely to emerge with the cards stacked so much in favor
of Salient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.55in">44.&#9;Additionally, the Merger Agreement
contains provisions that permit Salient to purchase ATS regardless of whether a majority of the Company&rsquo;s shareholders support
the deal or not. This is made more significant by the fact that various Individual Defendants and large holders of ATS common stock
have already entered into agreements that have effectively committed in excess of 40% of ATS&rsquo; shares in support of the deal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">45.&#9;Specifically,
Section 2.3 of the Merger Agreement (&ldquo;Section 2.3&rdquo;) provides for a &ldquo;Top-Up Option&rdquo; as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in; text-align: justify">(a) The Company hereby grants
to Merger Sub an irrevocable option (the <I>&ldquo;Top-Up Option&rdquo;) </I>to purchase at a price per share equal to the Offer
Price paid in the Offer, a number of newly issued shares of Company Common Stock (the <I>&ldquo;Top-Up Shares&rdquo;) </I>equal
to (and not less than) the lowest number of shares of Company Common Stock that, when added to the number of shares of Company
Common Stock directly or indirectly owned by Parent and Merger Sub at the time of exercise of the Top-Up Option following the Offer
Closing, shall constitute one share more than the number of shares necessary for the Merger Sub to be merged into the Company in
accordance with Section 253 of the DGCL.</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">46.&#9;The Top-Up Option ensures that
Salient will acquire control of at least 90% of the Company&rsquo;s outstanding common stock without regard to whether a single
shareholder tenders their shares in the Tender Offer, and squeeze out the Company&rsquo;s remaining common stockholders for the
entirely unfair price of $3.20 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">47.&#9;In reality,
Salient does not even have to pay ATS for the shares issued pursuant to the Top-Up Option. Pursuant to Section 2.3(b), the Top-Up
purchase price may be paid by issuance of a full-recourse promissory note which may be prepaid without premium or penalty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">48.&#9;Moreover,
although Delaware law provides that a plan of merger shall be approved by a majority of all the votes entitled to be cast on the
merger, the Merger Agreement itself demonstrates Defendants&rsquo; intent to facilitate Salient&rsquo;s acquisition of ATS without
such a vote. Section 8.2 of the Merger Agreement (Section 8.2) addresses Company Stockholder Adoption of the Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify">Notwithstanding the foregoing,
if Merger Sub acquires at least 90% of the outstanding shares of the Company Common Stock, the parties shall, at the request of
parent, take all necessary and appropriate action to cause the Merger to become effective as soon as practical after the expiration
of the Offering without a Company Stockholders Meeting in accordance with Section 253 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">49.<FONT STYLE="font-size: 10pt">&#9;</FONT>Accordingly,
the Company&rsquo;s true value is compromised by the consideration offered in the Proposed Acquisition and the Proposed Acquisition
is the product of the Board&rsquo;s breaches of fiduciary duty, aided and abetted by Salient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 1.7in"><B><U>THE 14D9 OMITS MATERIAL INFORMATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">50.<FONT STYLE="font-size: 10pt">&#9;</FONT>On
February 28, 2012, ATS filed the 14D9 with the SEC pursuant to which ATS&rsquo;s Board recommends that ATS stockholders tender
their shares in the Tender Offer and, if necessary, vote in favor of the Merger. As set forth below in detail, the 14D9 omits material
information about the Proposed Acquisition that must be disclosed to ATS&rsquo;s shareholders to enable them to make a fully informed
decision. This omitted information, if disclosed, would significantly alter the total mix of information available to them.</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.05in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.05in; text-align: justify; text-indent: 0.5in">51.&#9;It
is critical that the shareholders receive complete and accurate information about the Proposed Acquisition. To date, Defendants
have failed to provide the Company&rsquo;s shareholders with that information. For example, the 14D9 omits material information
with respect to the process and events leading up to the execution of the Merger Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">a.&#9;The 14D9 fails to disclose the identity
of the ATS stockholders who, in the fall of 2010, told management that they wanted ATS to consider a sale scenario, as well as
the reasoning provided by such stockholders for the sale of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">b.&#9;The 14D9 fails to disclose what prompted
the February 15, 2011 teleconference between Salient and Sagent and who contacted whom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">c.&#9;The 14D9 fails to disclose the basis
for the selection of the 99 potentially interested parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">d.&#9;The14D9 fails to disclose if any other
financial advisors, other than Sagent, were considered by ATS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">e.&#9;The 14D9 fails to disclose the specific
services Sagent previously provided to Salient, particularly with respect to its 2010 acquisition of SGIS where they claim to have
earned no fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 1in">f.&#9;The 14D-9 fails
to disclose the nature of the potential government contract issues identified by Salient and discussed by the Company on November
4, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 1in">g.&#9;The 14D-9 fails
to disclose the price range Sagent indicated to Salient that the Board would have likely found acceptable on January 30, 2012.</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">52.&#9;In addition to the disclosure deficiencies
set forth above, the 14D9 fails to disclose any remaining transaction terms that required negotiation after the Board had approved
the Company&rsquo;s entry into the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">53.&#9;The 14D9 also
omits material information with respect to the financial matters disclosed in the Preliminary Proxy, including the analyses conducted
by ATS&rsquo;s financial advisors, Sagent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">54.&#9;With respect
to Sagent, in rendering its fairness opinion, the 14D9 indicates Sagent&rsquo;s position that &ldquo;[biased upon and subject to
the foregoing, we are of the opinion that, as of the date hereof, the consideration to be offered to the stockholders of the Company
(other than Excluded Holders) in the Proposed Transaction is fair, from a financial point of view, to such stockholders. Based
on the completion of such a narrowly prescribed fairness opinion, as set forth herein, the 14D9 fails to provide adequate information
to evaluate both the deal and Sagent&rsquo;s analysis thereof as follows:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0"><B>a.</B></TD><TD STYLE="padding: 0"><B><I>Selected Public Company Analysis</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 1.5in">The 14D-9 fails to disclose:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.55in; padding: 0"></TD><TD STYLE="width: 0.45in; padding: 0">i.</TD><TD STYLE="padding: 0">The individually observed multiples and financial metrics for each of the selected companies.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.55in; padding: 0"></TD><TD STYLE="width: 0.45in; padding: 0">ii.</TD><TD STYLE="padding: 0">To which set of forecasts (Base or Adjusted) the selected multiples were applied.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.55in; padding: 0"></TD><TD STYLE="width: 0.45in; padding: 0">iii.</TD><TD STYLE="padding: 0">The amount of transaction fees and expenses, and any other additions, used to calculate adjusted net debt.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>b.</B></TD><TD STYLE="text-align: justify"><B><I>Selected Precedent Transactions Analysis</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 1.5in">The 14D-9 fails to disclose:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">i.</TD><TD STYLE="padding: 0">The individually observed multiples and financial metrics for each of the selected transactions.</TD></TR></TABLE>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">ii.</TD><TD STYLE="padding: 0">To which set of forecasts (Base or Adjusted) the selected multiples were applied.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">iii.</TD><TD STYLE="padding: 0">The amount of transaction fees and expenses, and any other additions, used to calculate adjusted net debt.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0"><B>c.</B></TD><TD STYLE="padding: 0"><B><I>Discounted Cash Flow Analysis</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 1in">The 14D-9 fails to disclose:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">i.</TD><TD STYLE="padding: 0">How stock-based compensation was treated in the analysis (i.e. cash or non-cash expense).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">ii.</TD><TD STYLE="padding: 0">The inputs and assumptions used by Sagent to derive the range of discount rates (15.5% to 16.5%).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">iii.</TD><TD STYLE="padding: 0">The implied perpetuity growth rates from this analysis.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">iv.</TD><TD STYLE="padding: 0">The amount of transaction fees and expenses, and any other additions, used to calculate adjusted net debt.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0"><B>d.</B></TD><TD STYLE="padding: 0"><B><I>Financial Projections</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-indent: 0.5in">The 14D-9 fails to disclose:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">i.</TD><TD STYLE="text-align: justify">Base Forecasts, for fiscal years 2011-2016, the following
items:</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">1.</TD><TD STYLE="padding: 0">Stock-based compensation expense.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">2.</TD><TD STYLE="padding: 0">Capital expenditures</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">3.</TD><TD STYLE="padding: 0">Changes in working capital</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">4.</TD><TD STYLE="padding: 0">Unlevered Free Cash Flow</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">ii.</TD><TD STYLE="padding: 0">Adjusted Forecasts: for fiscal years 2011-2016, the following items:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">1.</TD><TD STYLE="padding: 0">Net income,</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">2.</TD><TD STYLE="padding: 0">Depreciation and amortization,</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">3.</TD><TD STYLE="padding: 0">Interest,</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">4.</TD><TD STYLE="padding: 0">Taxes,</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">5.</TD><TD STYLE="padding: 0">Stock-based compensation expense,</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">6.</TD><TD STYLE="padding: 0">Capital expenditures,</TD></TR></TABLE>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">7.</TD><TD STYLE="padding: 0">Changes in working capital, and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in; padding: 0"></TD><TD STYLE="width: 0.5in; padding: 0">8.</TD><TD STYLE="padding: 0">Unlevered Free Cash Flow.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">55.&#9;As set forth herein, the Individual
Defendants, separately and together, in connection with the Proposed Acquisition, violated, and are violating, the fiduciary duties
they owe to Plaintiff and the other public shareholders of ATS, including their duties of loyalty, good faith, candor, and due
care. As a result of the Individual Defendants&rsquo; breaches of fiduciary duty, the Company&rsquo;s public shareholders will
not receive adequate or fair value for their common stock in the Proposed Acquisition and will be deprived of the ability to make
an informed decision on whether to tender their shares or vote in favor of the Merger Agreement. By reason of the foregoing, each
member of the Class will suffer irreparable injury and damages absent injunctive relief by this Court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">56.&#9;Plaintiff and other members of
the Class have no adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>CLASS ACTION ALLEGATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">57.&#9;Plaintiff brings this action individually
and as a class action on behalf of all holders of ATS common stock who are being and will be II<SUP>-</SUP>aimed by the Defendants&rsquo;
actions, described herein (the &ldquo;Class&rdquo;). Excluded from the Class are Defendants and any person, firm, trust, corporation
or other entity related to or affiliated with any Defendant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.55in"><I>58.<FONT STYLE="font-size: 10pt">&#9;</FONT></I>This
action is properly maintainable as a class action because, <I>inter alia:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">(a)&#9;The Class is so numerous that joinder
of all members is impracticable. ATS&rsquo; stock is publicly traded on the AMEX and there are approximately 27.97 million outstanding
shares. Plaintiff believes that there are hundreds if not thousands of holders of such shares. Moreover, the holders of these shares
are geographically dispersed throughout the United States;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 1in">(b)&#9;There are questions
of law and fact which are common to the Class including, <I>inter alia: </I>(i) whether the Individual Defendants have breached
their fiduciary duties to plaintiff and the Class by conducting an unreasonable sales process and agreeing to an acquisition transaction
at a price that is inadequate and is not the fair value that could be obtained under the circumstances; (ii) whether the Salient
Defendants aided and abetted the Individual Defendants&rsquo; breaches of fiduciary duty; and (iii) whether the Class is entitled
to injunctive relief and/or damages as a result of the wrongful conduct committed by Defendants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;</FONT>Plaintiff
is committed to prosecuting this action and has retained competent counsel experienced in litigation of this nature. The claims
of Plaintiff are typical of the claims of the other members of the Class and Plaintiff has the same interests as the other members
of the Class. Accordingly, Plaintiff is an adequate representative of the Class and will fairly and adequately protect the interests
of the Class:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">(d)&#9;The prosecution of separate actions
by individual members of the Class would create the risk of inconsistent or varying adjudications with respect to individual members
of the Class which would establish incompatible standards of conduct for Defendants, or adjudications with respect to individual
members of the Class which would, as a practical matter, be dispositive of the interests of the other members not parties to the
adjudications or substantially impair or impede their ability to protect their interests; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 1in">(e)&#9;Defendants have acted, or refused
to act, on grounds generally applicable to, and causing injury to, the Class and, therefore, preliminary and final injunctive relief
on behalf of the Class as a whole is appropriate.</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>FIRST COUNT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>Breach of Fiduciary Duty against the
Individual Defendants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">59.&#9;Plaintiff
incorporates each and every allegation set forth above as if fully set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">60.&#9;As alleged
herein, Defendants were bullied into selling the Company by certain large shareholders; purposefully and intentionally neglected
the business while seeking a buyer and, thus, agreed to sell ATS for inadequate consideration without ensuring that Plaintiff and
Class members would obtain adequate and fair consideration under the circumstances. Moreover, the Individual Defendants compounded
their breaches of fiduciary duty by failing to maximize shareholder value and obtain an adequate price for the Company. Indeed,
the stock price traded $0.05 per share higher than the offer price on February 17, 2012 &mdash; the last business day prior to
the announcement of the Proposed Acquisition, and the 20-day average closing price of ATS stock prior to the deal&rsquo;s announcement
was less than $0.01 below the offer price. The Individual Defendants are privy to non public information concerning the Company
that the public stock shareholders are not; thus, there exists a fiduciary duty to protect these shareholders and ensure the cash
out process entails both fair dealing and a fair price. Defendants have failed to sufficiently inform themselves of ATS&rsquo;
value, or have disregarded the true value of the Company. Furthermore, the Individual Defendants have agreed to onerous deal protection
devices that discourage any alternate acquirer from coming forward in the face of the knowledge that Salient can block the purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">61.&#9;As such, unless
the Individual Defendants&rsquo; conduct is enjoined by the Court, they will continue to breach their fiduciary duties to Plaintiff
and the other members of the Class, and will further a process that inhibits the maximization of shareholder value and the disclosure
of material information.</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">62.&#9;Plaintiff
and the members of the Class have no adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>SECOND COUNT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>Aiding and Abetting the Board&rsquo;s
Breaches of Fiduciary Duty<BR>
Against the Salient and ATS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">63.&#9;Plaintiff
incorporates each and every allegation set forth above as if fully set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">64.&#9;Salient and
ATS knowingly assisted the Individual Defendants&rsquo; breaches of fiduciary duty in connection with the Proposed Acquisition,
which, without such aid, would not have occurred. In connection with discussions regarding the Proposed Acquisition, the Salient
Defendants secured certain deal protection provisions which unfairly inhibit the advancement of alternative proposals. In addition,
Salient obtained sensitive non-public information concerning ATS&rsquo; operations and thus had the advantage to acquire the Company
at an unfair price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">65.&#9;As a result of this conduct, Plaintiff and the other
members of the Class have been and will be damaged in that they have been and will be prevented from obtaining a fair price for
their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">66.&#9;Plaintiff and the members of the
Class have no adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0.5in"><B>THIRD COUNT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0.5in"><B>Violations Of Rule
14(E) Promulgated Under The Securities Exchange Act Of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">67.&#9;Plaintiff
incorporates each and every allegation set forth above as if fully set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">68.&#9;During the
Relevant Period, defendants disseminated the false and misleading Solicitation/Recommendation Statement specified above which failed
to disclose material facts necessary in order to make the statements made, in light of the circumstances under which they were
made, not misleading.</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">69.&#9;The Solicitation/Recommendation
Statement violates Rule 14e because it omits material facts necessary to make the statements made not misleading, as set forth
in 1[11 51-54, <I>supra. </I>If Plaintiff and the other members of the Class were in possession of the facts that have been concealed
and omitted by Defendants, Plaintiff and other members of the Class would be materially less likely to vote their shares in favor
of the Proposed Acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">70.<FONT STYLE="font-size: 10pt">&#9;</FONT>In
the exercise of reasonable care, defendants knew or should have known that the Solicitation/Recommendation Statement was materially
false and misleading and would be relied upon by ATS shareholders in determining how to vote their shares in the upcoming vote
on the Proposed Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">WHEREFORE, Plaintiff
demands injunctive relief, in his favor and in favor of the Class, and against the Defendants. as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">A.&#9;Declaring that
this action is properly maintainable as a class action, certifying Plaintiff as Class representative and certifying his counsel
as class counsel;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">B.&#9;Temporarily
and permanently enjoining Defendants, their agents, counsel, employees and all persons acting in concert with them from consummating
the Proposed Acquisition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">C.&#9;To the extent
the Proposed Acquisition is consummated before entry of this Court&rsquo;s judgment, rescinding it and setting it aside or awarding
rescissory damages;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">D.&#9;Awarding Plaintiff
the costs and disbursements of this action, including reasonable attorneys&rsquo; and experts&rsquo; fees; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">E.&#9;Granting such
other and further relief as this Court may deem just and proper.</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Dated: March 6, 2012</P>

<P STYLE="font: 10pt/200% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.35pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: baseline">
    <TD STYLE="width: 50%; padding: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 50%; padding: 0; font-weight: bold">LAW OFFICES OF CHRISTIE A. LEARY, P.C.</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Christie A. Leary</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">State Bar I.D. # 463 10476 Armstrong</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Fairfax, Virginia A0</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Phone: (703) 3511</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Facsimile: (703) 43-5478</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; color: blue">&nbsp;</TD>
    <TD STYLE="padding: 0; color: blue; text-decoration: underline"><U>Email: Christie.leary@leary-law.com</U></TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Counsel for Plaintiff</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">OF COUNSEL:</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold">BRODSKY &amp; SMITH, LLC</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Evan J. Smith</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Marc L. Ackerman</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Two Bala Plaza, Suite 602</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Bala Cynwyd, PA 19004</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">(610) 667-6200</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><SUP>&nbsp;</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
